Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nfia
|
ENSMUSG00000028565.12 | nuclear factor I/A |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr4_97855762_97855913 | Nfia | 24282 | 0.232750 | 0.93 | 6.4e-03 | Click! |
chr4_97961063_97961267 | Nfia | 50132 | 0.172467 | -0.93 | 6.8e-03 | Click! |
chr4_97868417_97868573 | Nfia | 11624 | 0.274012 | 0.93 | 8.2e-03 | Click! |
chr4_98004240_98004601 | Nfia | 93387 | 0.083698 | 0.92 | 9.7e-03 | Click! |
chr4_97772757_97772930 | Nfia | 109 | 0.968431 | 0.91 | 1.1e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr13_31619653_31619819 | 11.62 |
Gm11378 |
predicted gene 11378 |
568 |
0.66 |
chr7_140772355_140773139 | 8.60 |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
8266 |
0.09 |
chr9_73050700_73050869 | 8.29 |
Rab27a |
RAB27A, member RAS oncogene family |
5800 |
0.09 |
chr16_30954001_30954179 | 7.67 |
Gm46565 |
predicted gene, 46565 |
18461 |
0.15 |
chr6_113991518_113991701 | 7.15 |
Gm15083 |
predicted gene 15083 |
13180 |
0.17 |
chr10_67185588_67186325 | 6.95 |
Jmjd1c |
jumonji domain containing 1C |
203 |
0.95 |
chr4_86990221_86990372 | 6.60 |
Slc24a2 |
solute carrier family 24 (sodium/potassium/calcium exchanger), member 2 |
21377 |
0.23 |
chr7_114290333_114290662 | 6.38 |
Psma1 |
proteasome subunit alpha 1 |
14379 |
0.21 |
chr6_71235183_71235374 | 6.14 |
Smyd1 |
SET and MYND domain containing 1 |
18404 |
0.1 |
chr13_56463247_56463576 | 6.06 |
Il9 |
interleukin 9 |
18835 |
0.14 |
chr4_109306572_109306746 | 6.05 |
Eps15 |
epidermal growth factor receptor pathway substrate 15 |
2194 |
0.33 |
chr3_107931566_107932141 | 6.00 |
Gstm7 |
glutathione S-transferase, mu 7 |
36 |
0.93 |
chr2_91130312_91130482 | 5.79 |
Madd |
MAP-kinase activating death domain |
8859 |
0.11 |
chr9_54156433_54156616 | 5.69 |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
25550 |
0.2 |
chr1_52597389_52597548 | 5.67 |
Gm5527 |
predicted gene 5527 |
12950 |
0.13 |
chr8_114982881_114983044 | 5.67 |
Gm22556 |
predicted gene, 22556 |
69951 |
0.14 |
chr7_80360672_80360826 | 5.66 |
Man2a2 |
mannosidase 2, alpha 2 |
838 |
0.42 |
chr5_27411249_27411405 | 5.61 |
Speer4b |
spermatogenesis associated glutamate (E)-rich protein 4B |
90035 |
0.09 |
chr4_137810112_137810287 | 5.50 |
Alpl |
alkaline phosphatase, liver/bone/kidney |
13815 |
0.19 |
chr11_98767825_98767976 | 5.32 |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
2526 |
0.15 |
chr1_82590345_82590504 | 5.31 |
Col4a3 |
collagen, type IV, alpha 3 |
3448 |
0.21 |
chr7_132616966_132617405 | 5.30 |
Lhpp |
phospholysine phosphohistidine inorganic pyrophosphate phosphatase |
3589 |
0.19 |
chr2_26342227_26342426 | 5.30 |
Gpsm1 |
G-protein signalling modulator 1 (AGS3-like, C. elegans) |
37 |
0.94 |
chr9_112743581_112744166 | 5.29 |
Gm24957 |
predicted gene, 24957 |
221344 |
0.02 |
chr18_60632933_60633113 | 5.20 |
Synpo |
synaptopodin |
3170 |
0.23 |
chr2_170176271_170176422 | 5.17 |
Zfp217 |
zinc finger protein 217 |
28243 |
0.22 |
chr12_86064762_86064921 | 5.07 |
Gm37804 |
predicted gene, 37804 |
4332 |
0.17 |
chr8_3211855_3212035 | 5.04 |
Insr |
insulin receptor |
19228 |
0.18 |
chr11_52257389_52257568 | 4.98 |
Tcf7 |
transcription factor 7, T cell specific |
17399 |
0.11 |
chr2_71719599_71719934 | 4.91 |
Platr26 |
pluripotency associated transcript 26 |
349 |
0.83 |
chr10_87787661_87787830 | 4.87 |
Igf1os |
insulin-like growth factor 1, opposite strand |
40617 |
0.16 |
chr1_93688304_93688651 | 4.84 |
Bok |
BCL2-related ovarian killer |
731 |
0.58 |
chrX_168959751_168959918 | 4.76 |
Arhgap6 |
Rho GTPase activating protein 6 |
76777 |
0.11 |
chr12_71224120_71224275 | 4.76 |
Gm19045 |
predicted gene, 19045 |
18753 |
0.16 |
chr18_47313549_47313714 | 4.73 |
Sema6a |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
19695 |
0.21 |
chr2_68873804_68874167 | 4.72 |
Cers6 |
ceramide synthase 6 |
12399 |
0.14 |
chr11_50156957_50157142 | 4.68 |
Tbc1d9b |
TBC1 domain family, member 9B |
4614 |
0.13 |
chr12_100265981_100266134 | 4.67 |
Gm10432 |
predicted gene 10432 |
10552 |
0.16 |
chr16_31651680_31651838 | 4.67 |
Dlg1 |
discs large MAGUK scaffold protein 1 |
11684 |
0.15 |
chr19_34881226_34881454 | 4.64 |
Pank1 |
pantothenate kinase 1 |
1885 |
0.31 |
chr9_77845751_77846338 | 4.58 |
Gm19572 |
predicted gene, 19572 |
5664 |
0.15 |
chr12_37050724_37050882 | 4.57 |
Gm48617 |
predicted gene, 48617 |
1586 |
0.37 |
chr7_16203156_16203319 | 4.55 |
Dhx34 |
DEAH (Asp-Glu-Ala-His) box polypeptide 34 |
964 |
0.4 |
chr6_86193078_86193250 | 4.53 |
Tgfa |
transforming growth factor alpha |
2059 |
0.28 |
chr6_142667828_142668019 | 4.48 |
Abcc9 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
34295 |
0.15 |
chr7_145056434_145056606 | 4.43 |
Gm45181 |
predicted gene 45181 |
106476 |
0.05 |
chr17_43330187_43330375 | 4.43 |
Adgrf5 |
adhesion G protein-coupled receptor F5 |
30170 |
0.2 |
chr3_129903790_129903943 | 4.38 |
Casp6 |
caspase 6 |
2365 |
0.24 |
chr15_89227137_89227295 | 4.35 |
Ppp6r2 |
protein phosphatase 6, regulatory subunit 2 |
15615 |
0.1 |
chr17_43329954_43330122 | 4.32 |
Adgrf5 |
adhesion G protein-coupled receptor F5 |
30413 |
0.2 |
chr2_84519705_84519896 | 4.31 |
Gm13710 |
predicted gene 13710 |
11522 |
0.16 |
chr7_35146051_35146625 | 4.31 |
Gm35665 |
predicted gene, 35665 |
4889 |
0.12 |
chr1_119173195_119173378 | 4.28 |
Gm8321 |
predicted gene 8321 |
15700 |
0.22 |
chr7_140763552_140763973 | 4.26 |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
23 |
0.95 |
chr4_46867682_46867844 | 4.25 |
Gabbr2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
7861 |
0.27 |
chr18_54921904_54922070 | 4.24 |
Zfp608 |
zinc finger protein 608 |
26425 |
0.17 |
chr6_101351206_101351526 | 4.23 |
Gm43946 |
predicted gene, 43946 |
2536 |
0.21 |
chr13_80895235_80895839 | 4.23 |
Arrdc3 |
arrestin domain containing 3 |
5019 |
0.18 |
chr5_111288285_111288766 | 4.21 |
Gm27680 |
predicted gene, 27680 |
42019 |
0.12 |
chr10_61337527_61337708 | 4.21 |
Pald1 |
phosphatase domain containing, paladin 1 |
4710 |
0.15 |
chr19_21152204_21152373 | 4.20 |
AC106834.1 |
novel transcript |
18553 |
0.2 |
chr17_25863718_25863900 | 4.19 |
Mcrip2 |
MAPK regulated corepressor interacting protein 2 |
459 |
0.51 |
chr7_4651233_4651574 | 4.18 |
Ppp6r1 |
protein phosphatase 6, regulatory subunit 1 |
3998 |
0.09 |
chr5_103835641_103835999 | 4.17 |
Klhl8 |
kelch-like 8 |
38549 |
0.12 |
chr19_3698215_3698368 | 4.16 |
Gm36608 |
predicted gene, 36608 |
9885 |
0.1 |
chr4_43181848_43182012 | 4.16 |
Unc13b |
unc-13 homolog B |
1362 |
0.39 |
chr11_16919693_16920246 | 4.15 |
Egfr |
epidermal growth factor receptor |
14784 |
0.17 |
chr11_31664337_31664509 | 4.12 |
Bod1 |
biorientation of chromosomes in cell division 1 |
7304 |
0.25 |
chr11_90372734_90372902 | 4.11 |
Hlf |
hepatic leukemia factor |
9117 |
0.27 |
chr12_70541574_70541915 | 4.11 |
Gm32219 |
predicted gene, 32219 |
19146 |
0.19 |
chr13_52941058_52941231 | 4.10 |
Auh |
AU RNA binding protein/enoyl-coenzyme A hydratase |
11463 |
0.19 |
chr3_123128727_123129043 | 4.09 |
Synpo2 |
synaptopodin 2 |
11833 |
0.14 |
chr12_71430131_71430651 | 4.08 |
1700083H02Rik |
RIKEN cDNA 1700083H02 gene |
46183 |
0.12 |
chr8_33653901_33654202 | 4.04 |
Gsr |
glutathione reductase |
813 |
0.57 |
chr13_38582858_38583013 | 4.03 |
Gm40922 |
predicted gene, 40922 |
28070 |
0.11 |
chr17_24000452_24000718 | 4.00 |
Prss22 |
protease, serine 22 |
2485 |
0.11 |
chr15_82905484_82905660 | 3.96 |
Tcf20 |
transcription factor 20 |
5761 |
0.15 |
chr4_99178772_99179088 | 3.94 |
Atg4c |
autophagy related 4C, cysteine peptidase |
15004 |
0.16 |
chr1_34388067_34388244 | 3.92 |
Gm5266 |
predicted gene 5266 |
20784 |
0.09 |
chr5_90560723_90560887 | 3.91 |
Albfm1 |
albumin superfamily member 1 |
302 |
0.83 |
chr11_58130484_58130897 | 3.88 |
Gm12246 |
predicted gene 12246 |
4622 |
0.12 |
chr19_55505247_55505422 | 3.86 |
Vti1a |
vesicle transport through interaction with t-SNAREs 1A |
124320 |
0.06 |
chr7_30731856_30732272 | 3.85 |
Tmem147os |
transmembrane protein 147, opposite strand |
642 |
0.36 |
chr16_85566937_85567088 | 3.85 |
Gm2541 |
predicted pseudogene 2541 |
13069 |
0.22 |
chr11_98764848_98765008 | 3.85 |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
5498 |
0.11 |
chr8_36435756_36436008 | 3.81 |
Gm19140 |
predicted gene, 19140 |
14498 |
0.17 |
chr1_73513962_73514123 | 3.81 |
Gm9553 |
predicted gene 9553 |
1996 |
0.31 |
chr18_34865352_34865513 | 3.77 |
Egr1 |
early growth response 1 |
4225 |
0.16 |
chr7_143588155_143588397 | 3.77 |
Gm15580 |
predicted gene 15580 |
8163 |
0.1 |
chr13_109604078_109604381 | 3.76 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
22824 |
0.29 |
chr9_50876975_50877171 | 3.76 |
Ppp2r1b |
protein phosphatase 2, regulatory subunit A, beta |
1012 |
0.49 |
chr19_36769025_36769205 | 3.76 |
Ppp1r3c |
protein phosphatase 1, regulatory subunit 3C |
32462 |
0.16 |
chr5_139320505_139320656 | 3.75 |
Adap1 |
ArfGAP with dual PH domains 1 |
5042 |
0.14 |
chr1_34389392_34389823 | 3.74 |
Gm5266 |
predicted gene 5266 |
22236 |
0.09 |
chr8_70702867_70703034 | 3.74 |
Iqcn |
IQ motif containing N |
507 |
0.55 |
chr13_53064801_53064962 | 3.73 |
Gm48336 |
predicted gene, 48336 |
35963 |
0.16 |
chr8_128465325_128465813 | 3.73 |
Nrp1 |
neuropilin 1 |
106172 |
0.06 |
chr14_65950035_65950186 | 3.73 |
Scara3 |
scavenger receptor class A, member 3 |
3825 |
0.19 |
chr4_9046133_9046293 | 3.72 |
Rps18-ps2 |
ribosomal protein S18, pseudogene 2 |
104954 |
0.07 |
chr1_187919033_187919184 | 3.72 |
Esrrg |
estrogen-related receptor gamma |
78719 |
0.1 |
chr9_106739177_106739334 | 3.70 |
Rad54l2 |
RAD54 like 2 (S. cerevisiae) |
16384 |
0.15 |
chr2_91476449_91476629 | 3.70 |
Lrp4 |
low density lipoprotein receptor-related protein 4 |
220 |
0.92 |
chr6_147064902_147065065 | 3.70 |
Mrps35 |
mitochondrial ribosomal protein S35 |
3732 |
0.16 |
chr8_121563179_121563404 | 3.70 |
Fbxo31 |
F-box protein 31 |
3328 |
0.14 |
chr6_117408053_117408216 | 3.69 |
Gm4640 |
predicted gene 4640 |
15483 |
0.22 |
chr4_63151085_63151285 | 3.69 |
Ambp |
alpha 1 microglobulin/bikunin precursor |
2988 |
0.23 |
chr19_10070675_10070831 | 3.69 |
Fads2 |
fatty acid desaturase 2 |
434 |
0.77 |
chr17_72904064_72904328 | 3.69 |
Lbh |
limb-bud and heart |
14109 |
0.23 |
chr18_46635034_46635483 | 3.68 |
Gm3734 |
predicted gene 3734 |
4451 |
0.18 |
chr18_84037791_84037957 | 3.68 |
Tshz1 |
teashirt zinc finger family member 1 |
47201 |
0.11 |
chr9_61325130_61325284 | 3.68 |
B930092H01Rik |
RIKEN cDNA B930092H01 gene |
31398 |
0.15 |
chr19_53404305_53404484 | 3.68 |
8030456M14Rik |
RIKEN cDNA 8030456M14 gene |
13605 |
0.12 |
chr15_10248990_10249545 | 3.67 |
Prlr |
prolactin receptor |
293 |
0.94 |
chr11_114868321_114868609 | 3.66 |
Gprc5c |
G protein-coupled receptor, family C, group 5, member C |
3973 |
0.16 |
chr10_78722102_78722266 | 3.65 |
Casp14 |
caspase 14 |
3890 |
0.13 |
chr12_104983771_104983923 | 3.63 |
Syne3 |
spectrin repeat containing, nuclear envelope family member 3 |
14830 |
0.12 |
chr10_30810298_30810917 | 3.61 |
Ncoa7 |
nuclear receptor coactivator 7 |
7281 |
0.16 |
chr10_84803461_84803623 | 3.61 |
Gm24226 |
predicted gene, 24226 |
7641 |
0.23 |
chr19_42659668_42660167 | 3.59 |
Gm25216 |
predicted gene, 25216 |
39985 |
0.13 |
chr2_4902402_4902728 | 3.59 |
Phyh |
phytanoyl-CoA hydroxylase |
16454 |
0.13 |
chr1_73930522_73930689 | 3.59 |
Tns1 |
tensin 1 |
100 |
0.97 |
chr3_69186771_69186937 | 3.58 |
Arl14 |
ADP-ribosylation factor-like 14 |
35565 |
0.13 |
chr7_100937600_100937760 | 3.58 |
Arhgef17 |
Rho guanine nucleotide exchange factor (GEF) 17 |
5573 |
0.15 |
chr16_17307555_17307706 | 3.57 |
Pi4ka |
phosphatidylinositol 4-kinase alpha |
100 |
0.95 |
chr4_19992397_19992575 | 3.56 |
4930480G23Rik |
RIKEN cDNA 4930480G23 gene |
13087 |
0.19 |
chr2_7426640_7426791 | 3.56 |
Celf2 |
CUGBP, Elav-like family member 2 |
30517 |
0.22 |
chr18_69690243_69690422 | 3.56 |
Tcf4 |
transcription factor 4 |
7952 |
0.3 |
chr6_143152309_143152506 | 3.56 |
Gm31108 |
predicted gene, 31108 |
1524 |
0.32 |
chr11_97455879_97456042 | 3.54 |
Arhgap23 |
Rho GTPase activating protein 23 |
3830 |
0.19 |
chr18_38390855_38391358 | 3.53 |
Ndfip1 |
Nedd4 family interacting protein 1 |
19290 |
0.12 |
chr19_55266780_55267136 | 3.52 |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
5912 |
0.19 |
chr2_3657810_3658181 | 3.52 |
Gm13183 |
predicted gene 13183 |
22595 |
0.15 |
chr5_32735922_32736077 | 3.52 |
Gm43695 |
predicted gene 43695 |
3335 |
0.14 |
chr9_25376297_25376471 | 3.52 |
Gm18891 |
predicted gene, 18891 |
26886 |
0.18 |
chr15_10223397_10223973 | 3.51 |
Prlr |
prolactin receptor |
301 |
0.94 |
chr16_23074853_23075004 | 3.51 |
Kng1 |
kininogen 1 |
16535 |
0.06 |
chr4_133084344_133084978 | 3.50 |
Ahdc1 |
AT hook, DNA binding motif, containing 1 |
18412 |
0.17 |
chr2_168518274_168518450 | 3.50 |
Nfatc2 |
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 2 |
33914 |
0.18 |
chr8_94178999_94179200 | 3.49 |
Mt1 |
metallothionein 1 |
17 |
0.95 |
chr8_12331810_12331970 | 3.47 |
Gm33175 |
predicted gene, 33175 |
12410 |
0.15 |
chr13_34814605_34814934 | 3.47 |
Gm47157 |
predicted gene, 47157 |
225 |
0.91 |
chr14_121108537_121108720 | 3.47 |
Farp1 |
FERM, RhoGEF (Arhgef) and pleckstrin domain protein 1 (chondrocyte-derived) |
6549 |
0.3 |
chr8_84130948_84131146 | 3.46 |
Podnl1 |
podocan-like 1 |
3229 |
0.09 |
chr17_75465392_75465653 | 3.46 |
Rasgrp3 |
RAS, guanyl releasing protein 3 |
36 |
0.99 |
chr8_125385601_125385967 | 3.46 |
Sipa1l2 |
signal-induced proliferation-associated 1 like 2 |
106926 |
0.07 |
chr11_3162901_3163088 | 3.46 |
Sfi1 |
Sfi1 homolog, spindle assembly associated (yeast) |
1603 |
0.26 |
chr15_81896525_81896724 | 3.46 |
Aco2 |
aconitase 2, mitochondrial |
1318 |
0.26 |
chr19_46484470_46484829 | 3.45 |
Sufu |
SUFU negative regulator of hedgehog signaling |
1552 |
0.33 |
chr10_44413232_44413410 | 3.45 |
Gm35028 |
predicted gene, 35028 |
11003 |
0.2 |
chr4_41596919_41597300 | 3.44 |
Dnaic1 |
dynein, axonemal, intermediate chain 1 |
27334 |
0.09 |
chr17_33947627_33947814 | 3.43 |
B3galt4 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4 |
3768 |
0.05 |
chr19_21941841_21942006 | 3.43 |
Ldhb-ps |
lactate dehydrogenase B, pseudogene |
4543 |
0.21 |
chr12_3858258_3858439 | 3.42 |
Dnmt3a |
DNA methyltransferase 3A |
2673 |
0.24 |
chr13_53125792_53125963 | 3.42 |
Gm48336 |
predicted gene, 48336 |
96959 |
0.07 |
chr2_22622037_22622208 | 3.42 |
Gad2 |
glutamic acid decarboxylase 2 |
83 |
0.96 |
chr15_25942411_25942580 | 3.42 |
Retreg1 |
reticulophagy regulator 1 |
184 |
0.95 |
chr11_94475826_94475993 | 3.42 |
Cacna1g |
calcium channel, voltage-dependent, T type, alpha 1G subunit |
1711 |
0.26 |
chr4_55014920_55015072 | 3.41 |
Zfp462 |
zinc finger protein 462 |
3516 |
0.32 |
chr1_39714360_39714642 | 3.41 |
Rfx8 |
regulatory factor X 8 |
6496 |
0.21 |
chr11_7201738_7201912 | 3.41 |
Igfbp1 |
insulin-like growth factor binding protein 1 |
4043 |
0.2 |
chr10_120421999_120422334 | 3.40 |
Mir763 |
microRNA 763 |
25944 |
0.15 |
chr19_8715090_8715269 | 3.39 |
Slc3a2 |
solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 |
746 |
0.29 |
chr18_20939203_20939371 | 3.39 |
Rnf125 |
ring finger protein 125 |
5338 |
0.23 |
chr15_68399262_68399413 | 3.38 |
Gm20732 |
predicted gene 20732 |
36161 |
0.13 |
chr3_27519044_27519213 | 3.37 |
Gm43344 |
predicted gene 43344 |
27513 |
0.21 |
chr10_108619351_108620201 | 3.37 |
Syt1 |
synaptotagmin I |
17188 |
0.25 |
chr2_140703231_140703416 | 3.37 |
Flrt3 |
fibronectin leucine rich transmembrane protein 3 |
31854 |
0.25 |
chr12_39951972_39952149 | 3.36 |
Gm18939 |
predicted gene, 18939 |
1428 |
0.43 |
chr8_10857974_10858150 | 3.36 |
Gm32540 |
predicted gene, 32540 |
8124 |
0.12 |
chr11_120789779_120789954 | 3.35 |
Dus1l |
dihydrouridine synthase 1-like (S. cerevisiae) |
16 |
0.94 |
chr14_121469692_121469843 | 3.35 |
Gm33299 |
predicted gene, 33299 |
14005 |
0.17 |
chr3_116189519_116189691 | 3.35 |
Gm31651 |
predicted gene, 31651 |
10803 |
0.15 |
chr17_56508000_56508177 | 3.33 |
Znrf4 |
zinc and ring finger 4 |
4343 |
0.16 |
chr8_115972507_115972692 | 3.33 |
Gm45733 |
predicted gene 45733 |
528 |
0.88 |
chr12_79630169_79630320 | 3.32 |
9430078K24Rik |
RIKEN cDNA 9430078K24 gene |
294489 |
0.01 |
chr11_94665403_94665559 | 3.32 |
Xylt2 |
xylosyltransferase II |
2321 |
0.16 |
chr2_33444795_33444946 | 3.32 |
Gm13536 |
predicted gene 13536 |
1932 |
0.27 |
chr10_59480782_59480968 | 3.32 |
Mcu |
mitochondrial calcium uniporter |
22715 |
0.18 |
chr1_74111655_74111806 | 3.31 |
Tns1 |
tensin 1 |
12717 |
0.15 |
chr16_21881277_21881450 | 3.30 |
Map3k13 |
mitogen-activated protein kinase kinase kinase 13 |
10606 |
0.13 |
chr6_85856155_85856513 | 3.30 |
Ptges3-ps |
prostaglandin E synthase 3, pseudogene |
12354 |
0.08 |
chr12_29390472_29390644 | 3.30 |
Gm6989 |
predicted gene 6989 |
72990 |
0.12 |
chr6_31066838_31067230 | 3.30 |
Gm27019 |
predicted gene, 27019 |
3539 |
0.14 |
chr3_55248629_55248787 | 3.29 |
Dclk1 |
doublecortin-like kinase 1 |
1429 |
0.43 |
chr4_129126149_129126469 | 3.29 |
Hpca |
hippocalcin |
4273 |
0.13 |
chr9_63702505_63702656 | 3.28 |
Smad3 |
SMAD family member 3 |
9389 |
0.23 |
chr7_141335657_141335846 | 3.28 |
Tmem80 |
transmembrane protein 80 |
2093 |
0.14 |
chr11_113742143_113742304 | 3.27 |
Cdc42ep4 |
CDC42 effector protein (Rho GTPase binding) 4 |
2901 |
0.2 |
chr2_153609102_153609438 | 3.27 |
Commd7 |
COMM domain containing 7 |
23461 |
0.15 |
chr7_140770124_140770422 | 3.26 |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
5792 |
0.1 |
chr13_48317548_48317729 | 3.26 |
Gm8588 |
predicted gene 8588 |
4968 |
0.19 |
chr15_96621805_96622214 | 3.25 |
Slc38a1 |
solute carrier family 38, member 1 |
19953 |
0.19 |
chr10_94573136_94573386 | 3.25 |
Tmcc3 |
transmembrane and coiled coil domains 3 |
1996 |
0.28 |
chr8_57147735_57147957 | 3.25 |
Gm17994 |
predicted gene, 17994 |
144206 |
0.04 |
chr5_120643893_120644074 | 3.24 |
Gm42657 |
predicted gene 42657 |
2362 |
0.13 |
chr17_47329074_47329231 | 3.24 |
Trerf1 |
transcriptional regulating factor 1 |
35083 |
0.1 |
chr2_75555745_75555902 | 3.24 |
Gm13655 |
predicted gene 13655 |
77559 |
0.07 |
chr4_150006215_150006386 | 3.24 |
H6pd |
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) |
2723 |
0.21 |
chr9_25455109_25455478 | 3.23 |
Gm8049 |
predicted gene 8049 |
4831 |
0.23 |
chr10_8752544_8752695 | 3.23 |
Sash1 |
SAM and SH3 domain containing 1 |
4142 |
0.25 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 10.0 | GO:0006868 | glutamine transport(GO:0006868) |
2.6 | 7.9 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
2.4 | 11.9 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
2.2 | 6.6 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
2.1 | 8.2 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
2.0 | 10.1 | GO:0009115 | xanthine catabolic process(GO:0009115) |
2.0 | 9.9 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.9 | 5.7 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.6 | 3.2 | GO:0021564 | vagus nerve development(GO:0021564) |
1.6 | 4.8 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
1.5 | 4.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
1.5 | 10.4 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
1.5 | 4.4 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
1.4 | 12.9 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
1.4 | 4.3 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
1.4 | 4.1 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
1.3 | 5.4 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
1.3 | 6.4 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
1.3 | 5.0 | GO:0009750 | response to fructose(GO:0009750) |
1.3 | 3.8 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.3 | 6.3 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
1.2 | 5.0 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
1.2 | 3.6 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
1.2 | 2.4 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
1.2 | 3.6 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
1.2 | 4.7 | GO:0072675 | osteoclast fusion(GO:0072675) |
1.2 | 3.5 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
1.1 | 1.1 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
1.1 | 3.4 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
1.1 | 3.3 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
1.1 | 3.3 | GO:0003032 | detection of oxygen(GO:0003032) |
1.1 | 3.3 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
1.1 | 4.3 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
1.1 | 4.3 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
1.1 | 4.3 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
1.1 | 5.3 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
1.1 | 3.2 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
1.1 | 5.3 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
1.0 | 3.1 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.0 | 3.1 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
1.0 | 3.1 | GO:0032439 | endosome localization(GO:0032439) |
1.0 | 4.2 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
1.0 | 14.5 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
1.0 | 4.1 | GO:1904395 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
1.0 | 4.1 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
1.0 | 5.2 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) |
1.0 | 1.0 | GO:0043383 | negative T cell selection(GO:0043383) |
1.0 | 3.1 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
1.0 | 4.1 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
1.0 | 3.1 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
1.0 | 1.0 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
1.0 | 3.0 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.0 | 3.0 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
1.0 | 3.0 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.0 | 2.0 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
1.0 | 2.9 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
1.0 | 2.9 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
1.0 | 1.0 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
1.0 | 1.9 | GO:0072223 | metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
1.0 | 2.9 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.9 | 0.9 | GO:0035384 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
0.9 | 2.8 | GO:0070384 | Harderian gland development(GO:0070384) |
0.9 | 2.8 | GO:0015888 | thiamine transport(GO:0015888) |
0.9 | 1.9 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.9 | 2.8 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.9 | 0.9 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.9 | 2.8 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.9 | 1.8 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.9 | 1.8 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.9 | 4.6 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.9 | 0.9 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
0.9 | 1.8 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
0.9 | 3.7 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.9 | 2.7 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.9 | 1.8 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.9 | 1.8 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.9 | 0.9 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.9 | 3.6 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.9 | 2.7 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.9 | 5.2 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.9 | 2.6 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.9 | 2.6 | GO:0034214 | protein hexamerization(GO:0034214) |
0.9 | 6.0 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.9 | 6.0 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.9 | 1.7 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.9 | 2.6 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.9 | 3.4 | GO:0072422 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.8 | 8.5 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.8 | 4.2 | GO:0015886 | heme transport(GO:0015886) |
0.8 | 1.7 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.8 | 2.5 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.8 | 2.5 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.8 | 0.8 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.8 | 1.7 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.8 | 1.6 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.8 | 2.5 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.8 | 4.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.8 | 4.1 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.8 | 3.2 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.8 | 0.8 | GO:0006848 | pyruvate transport(GO:0006848) |
0.8 | 2.4 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.8 | 3.2 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.8 | 1.6 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.8 | 3.2 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.8 | 5.6 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.8 | 0.8 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.8 | 2.4 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.8 | 5.5 | GO:0097264 | self proteolysis(GO:0097264) |
0.8 | 2.3 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.8 | 5.5 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.8 | 1.6 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.8 | 1.5 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.8 | 2.3 | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
0.8 | 1.5 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.8 | 1.5 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.8 | 2.3 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.8 | 0.8 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.8 | 1.5 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.8 | 2.3 | GO:0030242 | pexophagy(GO:0030242) |
0.8 | 4.5 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.8 | 3.0 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.8 | 1.5 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.7 | 3.7 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.7 | 2.2 | GO:1904220 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.7 | 1.5 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.7 | 3.0 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.7 | 0.7 | GO:1903416 | response to glycoside(GO:1903416) |
0.7 | 4.4 | GO:0015791 | polyol transport(GO:0015791) |
0.7 | 1.5 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.7 | 0.7 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.7 | 2.2 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.7 | 2.2 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.7 | 0.7 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.7 | 2.9 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.7 | 0.7 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.7 | 2.2 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.7 | 1.5 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.7 | 1.4 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.7 | 9.4 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.7 | 0.7 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.7 | 0.7 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.7 | 10.7 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.7 | 3.6 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.7 | 3.6 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.7 | 2.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.7 | 1.4 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.7 | 2.1 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.7 | 2.1 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.7 | 2.8 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.7 | 2.1 | GO:0032898 | neurotrophin production(GO:0032898) |
0.7 | 2.8 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.7 | 2.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.7 | 1.4 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
0.7 | 2.1 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.7 | 0.7 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.7 | 2.1 | GO:0010182 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.7 | 0.7 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.7 | 2.7 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.7 | 2.0 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.7 | 4.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.7 | 2.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.7 | 0.7 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.7 | 0.7 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.7 | 7.4 | GO:0051014 | actin filament severing(GO:0051014) |
0.7 | 3.4 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.7 | 0.7 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.7 | 2.6 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.7 | 2.6 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.7 | 2.0 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.7 | 3.3 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.7 | 1.3 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.7 | 0.7 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.7 | 1.3 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.6 | 2.6 | GO:0030091 | protein repair(GO:0030091) |
0.6 | 3.2 | GO:1904752 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) |
0.6 | 1.9 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.6 | 0.6 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.6 | 3.9 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.6 | 1.9 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.6 | 0.6 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.6 | 3.2 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.6 | 2.5 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.6 | 2.5 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.6 | 1.9 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.6 | 6.3 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.6 | 1.9 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.6 | 2.5 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.6 | 4.4 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.6 | 0.6 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.6 | 1.2 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.6 | 1.9 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.6 | 1.9 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.6 | 1.9 | GO:0002159 | desmosome assembly(GO:0002159) |
0.6 | 1.9 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.6 | 1.9 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.6 | 0.6 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.6 | 1.2 | GO:0033483 | gas homeostasis(GO:0033483) |
0.6 | 1.8 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.6 | 4.3 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.6 | 1.2 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.6 | 0.6 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
0.6 | 1.8 | GO:0051182 | coenzyme transport(GO:0051182) |
0.6 | 1.8 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.6 | 0.6 | GO:0034370 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
0.6 | 1.8 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.6 | 6.0 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.6 | 3.0 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.6 | 2.4 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.6 | 0.6 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.6 | 2.4 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.6 | 7.1 | GO:0046697 | decidualization(GO:0046697) |
0.6 | 3.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.6 | 1.2 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.6 | 1.7 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.6 | 1.2 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.6 | 2.9 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.6 | 1.2 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.6 | 0.6 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.6 | 6.9 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.6 | 1.2 | GO:0003130 | BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) |
0.6 | 1.7 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.6 | 1.1 | GO:1902075 | cellular response to salt(GO:1902075) |
0.6 | 1.7 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.6 | 6.8 | GO:0051601 | exocyst localization(GO:0051601) |
0.6 | 1.7 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.6 | 1.1 | GO:0045472 | response to ether(GO:0045472) |
0.6 | 2.8 | GO:0051013 | microtubule severing(GO:0051013) |
0.6 | 1.7 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.6 | 5.6 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.6 | 0.6 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.6 | 2.8 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.6 | 1.7 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.6 | 2.8 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.6 | 5.0 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.5 | 0.5 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.5 | 1.1 | GO:0003284 | septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
0.5 | 2.7 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.5 | 0.5 | GO:0015819 | lysine transport(GO:0015819) |
0.5 | 2.7 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.5 | 5.5 | GO:0007097 | nuclear migration(GO:0007097) |
0.5 | 0.5 | GO:0034391 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.5 | 2.7 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.5 | 5.4 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.5 | 0.5 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.5 | 1.6 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.5 | 1.6 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.5 | 0.5 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.5 | 2.1 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.5 | 1.6 | GO:0002432 | granuloma formation(GO:0002432) |
0.5 | 1.1 | GO:0043133 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.5 | 1.6 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.5 | 1.6 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.5 | 1.1 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.5 | 1.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.5 | 2.6 | GO:0051639 | actin filament network formation(GO:0051639) |
0.5 | 2.6 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.5 | 1.0 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.5 | 2.1 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.5 | 2.1 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.5 | 2.1 | GO:0060005 | vestibular reflex(GO:0060005) |
0.5 | 1.5 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.5 | 3.1 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.5 | 0.5 | GO:0002461 | tolerance induction dependent upon immune response(GO:0002461) |
0.5 | 1.0 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.5 | 1.5 | GO:1900221 | regulation of beta-amyloid clearance(GO:1900221) |
0.5 | 4.6 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.5 | 2.0 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.5 | 0.5 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.5 | 3.0 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.5 | 1.5 | GO:1904705 | regulation of vascular smooth muscle cell proliferation(GO:1904705) vascular smooth muscle cell proliferation(GO:1990874) |
0.5 | 1.5 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.5 | 1.0 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.5 | 0.5 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.5 | 0.5 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.5 | 0.5 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.5 | 1.5 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.5 | 1.5 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.5 | 2.0 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.5 | 1.0 | GO:0016264 | gap junction assembly(GO:0016264) |
0.5 | 1.5 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.5 | 6.9 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.5 | 2.0 | GO:0036257 | multivesicular body organization(GO:0036257) |
0.5 | 1.5 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.5 | 4.9 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.5 | 1.0 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.5 | 1.5 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.5 | 2.4 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.5 | 1.0 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.5 | 0.5 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.5 | 1.4 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.5 | 1.4 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.5 | 5.2 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.5 | 1.4 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.5 | 2.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.5 | 0.9 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.5 | 1.4 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.5 | 1.4 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.5 | 1.9 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.5 | 1.9 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.5 | 0.9 | GO:0035425 | autocrine signaling(GO:0035425) |
0.5 | 0.9 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.5 | 0.9 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.5 | 7.0 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.5 | 0.5 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.5 | 0.9 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.5 | 1.4 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.5 | 1.9 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.5 | 0.9 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.5 | 1.4 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.5 | 10.6 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.5 | 0.5 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.5 | 1.4 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.5 | 1.8 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.5 | 0.9 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.5 | 0.5 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.5 | 0.5 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.5 | 2.3 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.5 | 0.5 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.5 | 1.4 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.5 | 0.5 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.5 | 1.8 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.5 | 0.9 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.5 | 1.4 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.5 | 2.3 | GO:0015879 | carnitine transport(GO:0015879) |
0.5 | 0.5 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.5 | 1.4 | GO:0006116 | NADH oxidation(GO:0006116) |
0.5 | 2.3 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.5 | 0.9 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.5 | 1.8 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.4 | 0.4 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
0.4 | 0.4 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.4 | 3.6 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.4 | 0.4 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.4 | 0.4 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.4 | 1.3 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.4 | 1.3 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.4 | 3.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.4 | 0.4 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.4 | 1.7 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.4 | 1.7 | GO:0015825 | L-serine transport(GO:0015825) |
0.4 | 2.2 | GO:0051775 | response to redox state(GO:0051775) |
0.4 | 0.9 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.4 | 3.5 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.4 | 2.6 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.4 | 2.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.4 | 1.7 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.4 | 0.9 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.4 | 4.3 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.4 | 2.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.4 | 1.3 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.4 | 1.7 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.4 | 1.3 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.4 | 2.1 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.4 | 1.3 | GO:0050955 | thermoception(GO:0050955) |
0.4 | 0.9 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.4 | 0.9 | GO:0072718 | response to cisplatin(GO:0072718) |
0.4 | 1.3 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.4 | 1.3 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.4 | 0.4 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.4 | 0.4 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.4 | 0.8 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.4 | 0.8 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) |
0.4 | 0.8 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.4 | 1.7 | GO:0051697 | protein delipidation(GO:0051697) |
0.4 | 0.8 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.4 | 0.8 | GO:0002034 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.4 | 0.8 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.4 | 0.8 | GO:0051882 | mitochondrial depolarization(GO:0051882) |
0.4 | 2.1 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.4 | 0.8 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.4 | 2.9 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.4 | 1.2 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.4 | 1.7 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.4 | 0.4 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.4 | 1.2 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.4 | 0.8 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.4 | 1.6 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.4 | 1.6 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.4 | 0.8 | GO:0032909 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.4 | 0.8 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.4 | 0.4 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.4 | 1.2 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.4 | 0.8 | GO:0009299 | mRNA transcription(GO:0009299) |
0.4 | 4.1 | GO:0018904 | ether metabolic process(GO:0018904) |
0.4 | 1.6 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.4 | 0.8 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.4 | 3.2 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.4 | 0.8 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.4 | 4.0 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.4 | 2.0 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.4 | 2.0 | GO:0044351 | macropinocytosis(GO:0044351) |
0.4 | 0.8 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.4 | 1.2 | GO:0001302 | replicative cell aging(GO:0001302) |
0.4 | 2.4 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.4 | 1.2 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.4 | 4.4 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.4 | 1.6 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.4 | 2.4 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.4 | 1.2 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.4 | 0.4 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.4 | 1.2 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.4 | 0.8 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.4 | 2.0 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.4 | 1.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.4 | 2.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.4 | 1.6 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.4 | 1.2 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.4 | 0.4 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.4 | 1.6 | GO:0017085 | response to insecticide(GO:0017085) |
0.4 | 2.7 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.4 | 3.9 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.4 | 1.6 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.4 | 0.8 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.4 | 0.4 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.4 | 1.9 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.4 | 1.6 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.4 | 3.1 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.4 | 0.4 | GO:0050932 | regulation of pigment cell differentiation(GO:0050932) |
0.4 | 1.5 | GO:0001842 | neural fold formation(GO:0001842) |
0.4 | 0.8 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.4 | 1.5 | GO:0043373 | T-helper cell lineage commitment(GO:0002295) CD4-positive, alpha-beta T cell lineage commitment(GO:0043373) T-helper 17 cell lineage commitment(GO:0072540) |
0.4 | 1.5 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.4 | 1.2 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.4 | 0.4 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.4 | 1.5 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
0.4 | 1.1 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.4 | 0.4 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.4 | 0.4 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.4 | 0.8 | GO:0070268 | cornification(GO:0070268) |
0.4 | 0.4 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.4 | 1.9 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.4 | 1.1 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.4 | 3.4 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.4 | 1.1 | GO:0010453 | regulation of cell fate commitment(GO:0010453) |
0.4 | 0.8 | GO:0033622 | integrin activation(GO:0033622) |
0.4 | 1.1 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.4 | 2.3 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.4 | 1.1 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.4 | 1.5 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.4 | 1.5 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.4 | 0.7 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.4 | 0.4 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.4 | 1.1 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.4 | 1.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.4 | 1.5 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.4 | 0.7 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
0.4 | 0.4 | GO:0034443 | regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) |
0.4 | 1.9 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.4 | 2.2 | GO:0006907 | pinocytosis(GO:0006907) |
0.4 | 0.7 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.4 | 2.2 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.4 | 0.4 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.4 | 0.4 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.4 | 0.7 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.4 | 1.1 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.4 | 0.4 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.4 | 1.4 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.4 | 1.4 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.4 | 1.1 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.4 | 1.4 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.4 | 1.4 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.4 | 1.4 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.4 | 1.1 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.4 | 1.8 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.4 | 3.2 | GO:0043482 | cellular pigment accumulation(GO:0043482) |
0.4 | 1.1 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.4 | 0.7 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.4 | 3.2 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.4 | 0.4 | GO:0010042 | response to manganese ion(GO:0010042) |
0.4 | 3.5 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.4 | 1.4 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.4 | 2.5 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.4 | 1.1 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.4 | 1.8 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.3 | 1.0 | GO:0008228 | opsonization(GO:0008228) |
0.3 | 0.3 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.3 | 1.7 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.3 | 0.7 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.3 | 1.7 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.3 | 0.3 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.3 | 2.4 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.3 | 2.4 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.3 | 0.3 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.3 | 3.8 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.3 | 1.0 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.3 | 0.7 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.3 | 0.7 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.3 | 1.4 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.3 | 0.3 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.3 | 1.0 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.3 | 3.7 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.3 | 1.4 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.3 | 0.3 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.3 | 1.7 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.3 | 1.0 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.3 | 1.7 | GO:1904666 | regulation of ubiquitin protein ligase activity(GO:1904666) positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.3 | 2.3 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.3 | 1.0 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.3 | 1.3 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.3 | 3.7 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.3 | 1.7 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.3 | 1.0 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.3 | 0.3 | GO:0051794 | regulation of catagen(GO:0051794) |
0.3 | 0.7 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.3 | 1.3 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.3 | 0.3 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.3 | 0.7 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.3 | 4.3 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.3 | 0.7 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
0.3 | 1.0 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.3 | 0.7 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.3 | 0.7 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.3 | 0.7 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.3 | 2.6 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.3 | 0.3 | GO:0070459 | prolactin secretion(GO:0070459) |
0.3 | 0.6 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.3 | 7.7 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
0.3 | 1.3 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.3 | 1.0 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.3 | 1.0 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.3 | 1.9 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.3 | 0.6 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.3 | 0.6 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.3 | 1.6 | GO:0019695 | choline metabolic process(GO:0019695) |
0.3 | 0.3 | GO:0033058 | directional locomotion(GO:0033058) |
0.3 | 1.0 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.3 | 1.9 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.3 | 2.2 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.3 | 0.6 | GO:0044838 | cell quiescence(GO:0044838) |
0.3 | 1.6 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.3 | 0.6 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.3 | 0.9 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.3 | 0.6 | GO:0097503 | sialylation(GO:0097503) |
0.3 | 0.3 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.3 | 1.3 | GO:0071679 | commissural neuron axon guidance(GO:0071679) |
0.3 | 2.5 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.3 | 0.9 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.3 | 3.1 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.3 | 1.6 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.3 | 0.3 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.3 | 0.9 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.3 | 1.6 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.3 | 0.9 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.3 | 0.6 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.3 | 0.6 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.3 | 1.9 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.3 | 0.9 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.3 | 0.6 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.3 | 2.7 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.3 | 1.5 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.3 | 1.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.3 | 0.3 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.3 | 0.6 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.3 | 0.3 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.3 | 0.9 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.3 | 0.3 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.3 | 0.9 | GO:1903053 | regulation of extracellular matrix organization(GO:1903053) |
0.3 | 2.4 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.3 | 0.9 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.3 | 1.8 | GO:0051324 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.3 | 0.3 | GO:0021856 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
0.3 | 2.1 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.3 | 0.6 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.3 | 1.8 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.3 | 0.6 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.3 | 1.8 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.3 | 0.9 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.3 | 0.3 | GO:1904938 | dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
0.3 | 1.8 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.3 | 3.5 | GO:0040033 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.3 | 0.3 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.3 | 0.6 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.3 | 0.6 | GO:0090579 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
0.3 | 0.9 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.3 | 1.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.3 | 0.6 | GO:0009629 | response to gravity(GO:0009629) |
0.3 | 0.6 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.3 | 0.3 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.3 | 1.5 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.3 | 0.3 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.3 | 0.3 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.3 | 1.4 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.3 | 1.4 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.3 | 0.6 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.3 | 0.9 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.3 | 0.3 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.3 | 2.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 | 1.1 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.3 | 0.3 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.3 | 0.6 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.3 | 0.3 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.3 | 1.4 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.3 | 0.3 | GO:0060594 | mammary gland specification(GO:0060594) |
0.3 | 0.3 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.3 | 3.7 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.3 | 0.3 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.3 | 0.8 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.3 | 0.6 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.3 | 0.6 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.3 | 2.0 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.3 | 0.6 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.3 | 0.8 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.3 | 0.3 | GO:0010159 | specification of organ position(GO:0010159) |
0.3 | 4.8 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.3 | 1.4 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.3 | 0.3 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.3 | 0.3 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.3 | 0.6 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.3 | 0.3 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.3 | 0.3 | GO:0022009 | central nervous system vasculogenesis(GO:0022009) |
0.3 | 0.3 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.3 | 0.3 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.3 | 1.4 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.3 | 2.2 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.3 | 0.8 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.3 | 4.7 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.3 | 0.8 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.3 | 0.5 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.3 | 2.2 | GO:0050957 | equilibrioception(GO:0050957) |
0.3 | 0.5 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.3 | 0.8 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.3 | 0.5 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.3 | 1.9 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.3 | 5.1 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.3 | 0.5 | GO:0045581 | negative regulation of T cell differentiation(GO:0045581) |
0.3 | 2.2 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.3 | 0.5 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.3 | 1.3 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.3 | 0.8 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.3 | 0.3 | GO:0015755 | fructose transport(GO:0015755) |
0.3 | 0.3 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.3 | 1.6 | GO:0015677 | copper ion import(GO:0015677) |
0.3 | 1.9 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.3 | 0.3 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.3 | 0.8 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.3 | 0.5 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.3 | 26.4 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.3 | 0.3 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.3 | 1.9 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 1.9 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.3 | 0.8 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.3 | 0.3 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.3 | 1.1 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.3 | 0.8 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.3 | 1.3 | GO:0010665 | regulation of cardiac muscle cell apoptotic process(GO:0010665) |
0.3 | 0.3 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.3 | 0.5 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.3 | 1.3 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.3 | 1.3 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.3 | 1.0 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.3 | 1.0 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.3 | 0.5 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.3 | 0.5 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.3 | 2.9 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.3 | 0.5 | GO:0006222 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.3 | 0.5 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.3 | 1.6 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.3 | 0.5 | GO:0001768 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.3 | 0.5 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.3 | 2.6 | GO:0014850 | response to muscle activity(GO:0014850) |
0.3 | 0.8 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.3 | 0.3 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.3 | 0.3 | GO:0001562 | response to protozoan(GO:0001562) |
0.3 | 1.3 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.3 | 9.2 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.3 | 9.2 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.3 | 2.0 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.3 | 11.0 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.3 | 0.5 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.3 | 0.8 | GO:1903147 | regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) negative regulation of mitophagy(GO:1903147) |
0.3 | 0.8 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.3 | 0.3 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.3 | 0.8 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.3 | 0.8 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.3 | 0.8 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.3 | 0.8 | GO:0007350 | blastoderm segmentation(GO:0007350) |
0.3 | 1.0 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.3 | 0.3 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.3 | 0.8 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.3 | 0.3 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.3 | 0.3 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.3 | 2.3 | GO:0071548 | response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
0.3 | 0.3 | GO:0030421 | defecation(GO:0030421) |
0.3 | 0.5 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.3 | 1.3 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.2 | 2.7 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
0.2 | 0.7 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.2 | 1.0 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.2 | 0.5 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.2 | 0.7 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.2 | 1.0 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 2.0 | GO:0002347 | response to tumor cell(GO:0002347) |
0.2 | 0.7 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.2 | 1.0 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.2 | 1.7 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.2 | 0.5 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.2 | 0.7 | GO:0007525 | somatic muscle development(GO:0007525) |
0.2 | 2.7 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 0.5 | GO:0048069 | eye pigmentation(GO:0048069) |
0.2 | 3.2 | GO:0001945 | lymph vessel development(GO:0001945) |
0.2 | 0.5 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.2 | 1.0 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.2 | 0.5 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.2 | 0.5 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
0.2 | 0.2 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.2 | 1.5 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.2 | 0.2 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.2 | 0.7 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 0.2 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.2 | 1.5 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.2 | 0.2 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.2 | 2.7 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.2 | 0.5 | GO:0015846 | polyamine transport(GO:0015846) |
0.2 | 0.5 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.2 | 0.7 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 1.7 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.2 | 2.2 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.2 | 0.7 | GO:0040031 | snRNA modification(GO:0040031) |
0.2 | 0.7 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 0.5 | GO:0048840 | otolith development(GO:0048840) |
0.2 | 2.4 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.2 | 0.7 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.2 | 0.5 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.2 | 0.5 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.2 | 3.8 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.2 | 1.2 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.2 | 1.2 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.2 | 0.7 | GO:0007296 | vitellogenesis(GO:0007296) |
0.2 | 0.7 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.2 | 3.8 | GO:0000578 | embryonic axis specification(GO:0000578) |
0.2 | 1.7 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.2 | 0.2 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.2 | 0.7 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.2 | 1.2 | GO:0007135 | meiosis II(GO:0007135) |
0.2 | 0.7 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.2 | 0.9 | GO:0051181 | cofactor transport(GO:0051181) |
0.2 | 0.5 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.2 | 0.9 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.2 | 0.5 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.2 | 0.7 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.2 | 0.7 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.2 | 3.2 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 0.5 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.2 | 0.9 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.2 | 0.5 | GO:0060534 | trachea cartilage development(GO:0060534) |
0.2 | 0.7 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.2 | 0.7 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
0.2 | 0.2 | GO:1902339 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.2 | 0.2 | GO:1901626 | regulation of postsynaptic membrane organization(GO:1901626) |
0.2 | 0.7 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.2 | 0.9 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.2 | 1.1 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 0.5 | GO:2000774 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
0.2 | 2.3 | GO:0051383 | kinetochore organization(GO:0051383) |
0.2 | 1.3 | GO:0044804 | nucleophagy(GO:0044804) |
0.2 | 0.4 | GO:1903337 | positive regulation of vacuolar transport(GO:1903337) |
0.2 | 3.1 | GO:0045061 | thymic T cell selection(GO:0045061) |
0.2 | 0.4 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.2 | 0.4 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.2 | 0.7 | GO:0043312 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.2 | 0.4 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.2 | 0.9 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 0.4 | GO:1904396 | regulation of neuromuscular junction development(GO:1904396) |
0.2 | 7.1 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.2 | 0.4 | GO:0042119 | neutrophil activation(GO:0042119) |
0.2 | 0.4 | GO:0070836 | caveola assembly(GO:0070836) |
0.2 | 0.2 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.2 | 0.7 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 0.4 | GO:0060596 | mammary placode formation(GO:0060596) |
0.2 | 0.4 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.2 | 2.7 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.2 | 2.9 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.2 | 2.2 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.2 | 1.3 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.2 | 0.7 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
0.2 | 1.1 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.2 | 0.9 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.2 | 0.4 | GO:0002254 | kinin cascade(GO:0002254) |
0.2 | 0.9 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.2 | 0.4 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.2 | 0.2 | GO:0060157 | urinary bladder development(GO:0060157) |
0.2 | 3.9 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.2 | 1.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 0.2 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.2 | 0.4 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.2 | 2.4 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.2 | 0.2 | GO:0048818 | positive regulation of hair follicle maturation(GO:0048818) |
0.2 | 0.6 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.2 | 2.2 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.2 | 0.6 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.2 | 0.2 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.2 | 0.4 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.2 | 0.4 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.2 | 1.3 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.2 | 0.2 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.2 | 0.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 0.9 | GO:0070572 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.2 | 0.6 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.2 | 1.9 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.2 | 0.2 | GO:1903802 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.2 | 0.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 0.4 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.2 | 0.2 | GO:0051532 | regulation of NFAT protein import into nucleus(GO:0051532) |
0.2 | 0.6 | GO:0051194 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.2 | 0.4 | GO:1903242 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.2 | 0.6 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.2 | 0.6 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.2 | 2.5 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.2 | 1.9 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.2 | 0.2 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.2 | 0.2 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.2 | 0.4 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.2 | 0.8 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.2 | 1.3 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.2 | 0.2 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.2 | 0.6 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.2 | 0.4 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.2 | 14.7 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.2 | 0.4 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.2 | 1.0 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.2 | 1.9 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.2 | 0.4 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.2 | 1.0 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.2 | 1.7 | GO:0016926 | protein desumoylation(GO:0016926) |
0.2 | 0.6 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.2 | 2.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.2 | 0.4 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.2 | 2.3 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.2 | 1.0 | GO:0036233 | glycine import(GO:0036233) |
0.2 | 0.4 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.2 | 0.4 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.2 | 0.2 | GO:0042148 | strand invasion(GO:0042148) |
0.2 | 0.2 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.2 | 0.4 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.2 | 0.4 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.2 | 0.6 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.2 | 1.2 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.2 | 0.6 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.2 | 0.4 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.2 | 0.2 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.2 | 0.6 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.2 | 0.2 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.2 | 0.8 | GO:1903044 | protein transport into membrane raft(GO:0032596) protein localization to membrane raft(GO:1903044) |
0.2 | 2.2 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.2 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.2 | 0.2 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.2 | 0.2 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.2 | 1.0 | GO:0007625 | grooming behavior(GO:0007625) |
0.2 | 0.4 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.2 | 0.2 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.2 | 1.4 | GO:0090314 | positive regulation of protein targeting to membrane(GO:0090314) |
0.2 | 0.4 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.2 | 2.6 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.2 | 1.0 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.2 | 1.0 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.2 | 0.2 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.2 | 0.4 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.2 | 0.2 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.2 | 1.0 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.2 | 0.6 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.2 | 0.2 | GO:0031579 | membrane raft organization(GO:0031579) |
0.2 | 0.4 | GO:0051031 | tRNA transport(GO:0051031) |
0.2 | 0.6 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.2 | 0.2 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.2 | 2.9 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.2 | 0.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.2 | 0.6 | GO:0060561 | apoptotic process involved in morphogenesis(GO:0060561) |
0.2 | 0.8 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.2 | 0.4 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.2 | 0.2 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.2 | 0.4 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.2 | 0.2 | GO:0001660 | fever generation(GO:0001660) |
0.2 | 0.6 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.2 | 0.6 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.2 | 0.2 | GO:1902896 | terminal web assembly(GO:1902896) |
0.2 | 0.2 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.2 | 1.9 | GO:0019915 | lipid storage(GO:0019915) |
0.2 | 0.4 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 0.4 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.2 | 0.8 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.2 | 0.2 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.2 | 0.2 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.2 | 0.6 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.2 | 0.2 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.2 | 2.8 | GO:0035306 | positive regulation of dephosphorylation(GO:0035306) |
0.2 | 0.4 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.2 | 0.6 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.2 | 0.2 | GO:0035989 | tendon development(GO:0035989) |
0.2 | 0.6 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.2 | 0.2 | GO:0086014 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
0.2 | 0.2 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
0.2 | 0.6 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.2 | 0.7 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.2 | 0.6 | GO:0072603 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
0.2 | 0.2 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.2 | 1.7 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
0.2 | 0.2 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.2 | 0.4 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.2 | 1.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 0.6 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.2 | 0.6 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.2 | 1.1 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.2 | 0.2 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.2 | 1.1 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.2 | 0.9 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.2 | 3.1 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.2 | 1.1 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.2 | 0.2 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.2 | 6.9 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.2 | 0.5 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.2 | 1.6 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.2 | 0.7 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.2 | 1.3 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.2 | 1.6 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.2 | 0.7 | GO:0032202 | telomere assembly(GO:0032202) |
0.2 | 0.7 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.2 | 0.7 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.2 | 0.2 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.2 | 0.9 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.2 | 0.4 | GO:1903288 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.2 | 0.4 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.2 | 0.5 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.2 | 0.4 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.2 | 0.9 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.2 | 1.1 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.2 | 0.4 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 0.4 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.2 | 0.2 | GO:0051610 | serotonin uptake(GO:0051610) |
0.2 | 1.9 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.2 | 0.2 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.2 | 1.1 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.2 | 2.6 | GO:0030488 | tRNA methylation(GO:0030488) |
0.2 | 2.4 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.2 | 0.5 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.2 | 0.5 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.2 | 0.2 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.2 | 2.8 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.2 | 0.5 | GO:0035927 | RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) rRNA transport(GO:0051029) |
0.2 | 0.2 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.2 | 0.3 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.2 | 1.6 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.2 | 1.7 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.2 | 0.2 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.2 | 0.3 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.2 | 3.4 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.2 | 0.3 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.2 | 0.3 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.2 | 0.7 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.2 | 2.0 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.2 | 0.2 | GO:0048289 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
0.2 | 0.3 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.2 | 1.2 | GO:0035813 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
0.2 | 4.7 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.2 | 0.7 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.2 | 0.5 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.2 | 0.3 | GO:0046636 | negative regulation of alpha-beta T cell activation(GO:0046636) |
0.2 | 0.5 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.2 | 0.3 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.2 | 0.5 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.2 | 1.2 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.2 | 0.7 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.2 | 1.3 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.2 | 0.8 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 0.8 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.2 | 0.3 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.2 | 1.3 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.2 | 0.2 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.2 | 0.7 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.2 | 3.3 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.2 | 0.7 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 0.2 | GO:0085029 | extracellular matrix assembly(GO:0085029) |
0.2 | 1.5 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.2 | 1.1 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.2 | 1.0 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.2 | 0.5 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.2 | 0.8 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 1.8 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.2 | 0.3 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.2 | 0.2 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.2 | 0.6 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.2 | 0.3 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.2 | 0.5 | GO:0032511 | endosome transport via multivesicular body sorting pathway(GO:0032509) late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.2 | 0.2 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.2 | 1.0 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 0.6 | GO:0090128 | regulation of synapse maturation(GO:0090128) |
0.2 | 1.0 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.2 | 0.6 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.2 | 0.6 | GO:0099625 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.2 | 1.3 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.2 | 1.3 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.2 | 0.2 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.2 | 2.8 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
0.2 | 0.3 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.2 | 2.7 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.2 | 0.2 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.2 | 1.1 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.2 | 1.6 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.2 | 0.8 | GO:0070417 | cellular response to cold(GO:0070417) |
0.2 | 0.5 | GO:1902218 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.2 | 0.2 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.2 | 0.9 | GO:2000737 | negative regulation of stem cell differentiation(GO:2000737) |
0.2 | 1.6 | GO:1990090 | response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
0.2 | 0.3 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.2 | 3.4 | GO:0007569 | cell aging(GO:0007569) |
0.2 | 1.4 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.2 | 3.7 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.2 | 2.2 | GO:0003016 | respiratory system process(GO:0003016) |
0.2 | 0.5 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.2 | 1.9 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
0.2 | 0.3 | GO:0014831 | intestine smooth muscle contraction(GO:0014827) gastro-intestinal system smooth muscle contraction(GO:0014831) |
0.2 | 0.2 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.2 | 1.1 | GO:0007614 | short-term memory(GO:0007614) |
0.2 | 0.9 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.2 | 2.2 | GO:0045214 | sarcomere organization(GO:0045214) |
0.2 | 0.2 | GO:0071726 | response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
0.2 | 1.2 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 1.8 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 0.3 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.2 | 0.3 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.2 | 0.2 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.2 | 0.2 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.2 | 0.5 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.2 | 0.5 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.2 | 0.6 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.2 | 0.3 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.2 | 3.3 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.2 | 0.3 | GO:0097035 | regulation of membrane lipid distribution(GO:0097035) |
0.2 | 0.8 | GO:0036003 | positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) |
0.2 | 1.4 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.2 | 0.5 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.2 | 3.0 | GO:0006301 | postreplication repair(GO:0006301) |
0.2 | 0.9 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 0.6 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.2 | 0.8 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.1 | 0.4 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 0.3 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 0.1 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.1 | 3.9 | GO:0006721 | terpenoid metabolic process(GO:0006721) |
0.1 | 0.1 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) negative regulation of sodium ion transmembrane transport(GO:1902306) negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.1 | 0.9 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.1 | GO:0045073 | chemokine biosynthetic process(GO:0042033) regulation of chemokine biosynthetic process(GO:0045073) |
0.1 | 0.1 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.1 | 0.4 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 1.5 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.1 | 0.1 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.1 | 0.4 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.1 | 2.0 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.1 | 0.4 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.3 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 1.2 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.1 | 1.2 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 1.7 | GO:0001662 | behavioral fear response(GO:0001662) |
0.1 | 0.9 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.1 | 0.4 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) ketone body biosynthetic process(GO:0046951) |
0.1 | 0.4 | GO:0071625 | vocalization behavior(GO:0071625) |
0.1 | 0.4 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.1 | 0.1 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.1 | 0.8 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.3 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.1 | 1.7 | GO:0007616 | long-term memory(GO:0007616) |
0.1 | 1.0 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 0.3 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.1 | 1.7 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.1 | GO:0051006 | positive regulation of lipoprotein lipase activity(GO:0051006) |
0.1 | 0.6 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.1 | 0.7 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.7 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.1 | 1.2 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.1 | 0.3 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.1 | 0.4 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.3 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.1 | 0.5 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.1 | 0.5 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.7 | GO:0007398 | ectoderm development(GO:0007398) |
0.1 | 0.4 | GO:0033198 | response to ATP(GO:0033198) |
0.1 | 0.8 | GO:0032272 | negative regulation of protein polymerization(GO:0032272) |
0.1 | 0.3 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.1 | 0.1 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.1 | 0.7 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.9 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.1 | 0.9 | GO:0097369 | sodium ion import(GO:0097369) |
0.1 | 0.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.7 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 0.4 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.3 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.1 | 0.4 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.1 | 0.5 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.1 | GO:0003093 | regulation of glomerular filtration(GO:0003093) |
0.1 | 0.8 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.1 | 0.1 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.1 | 1.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.4 | GO:0035587 | purinergic receptor signaling pathway(GO:0035587) |
0.1 | 0.1 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.1 | 0.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.7 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.3 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.1 | 0.1 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.1 | 0.1 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.1 | 0.4 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.1 | 0.5 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.3 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 0.5 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 1.6 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.1 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.1 | 0.5 | GO:0006189 | IMP biosynthetic process(GO:0006188) 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.4 | GO:2000765 | regulation of cytoplasmic translation(GO:2000765) |
0.1 | 0.4 | GO:0071042 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.1 | 1.3 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.1 | 0.1 | GO:0032196 | transposition(GO:0032196) |
0.1 | 0.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.3 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.1 | 0.6 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.1 | 0.1 | GO:0031652 | positive regulation of heat generation(GO:0031652) |
0.1 | 0.1 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.1 | 2.5 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 0.1 | GO:0051299 | centrosome separation(GO:0051299) |
0.1 | 0.3 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
0.1 | 0.4 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.6 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.1 | 0.1 | GO:0099623 | regulation of cardiac muscle cell membrane repolarization(GO:0099623) |
0.1 | 0.1 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.1 | 0.7 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.1 | 0.5 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 2.0 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.1 | 0.5 | GO:0032095 | regulation of response to food(GO:0032095) |
0.1 | 0.4 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 0.2 | GO:0014717 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.1 | 0.1 | GO:0090382 | phagosome maturation(GO:0090382) |
0.1 | 2.3 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.2 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 0.1 | GO:1901563 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) cellular response to camptothecin(GO:0072757) response to camptothecin(GO:1901563) |
0.1 | 0.5 | GO:0021554 | optic nerve development(GO:0021554) |
0.1 | 0.1 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.1 | 0.8 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 3.2 | GO:0030042 | actin filament depolymerization(GO:0030042) |
0.1 | 0.5 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.1 | 0.5 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 1.6 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 1.1 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.1 | 3.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 0.5 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.1 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.1 | 1.2 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.1 | 0.5 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
0.1 | 0.5 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.1 | 0.4 | GO:0031054 | pre-miRNA processing(GO:0031054) |
0.1 | 1.1 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.1 | 0.5 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 0.6 | GO:0038179 | neurotrophin signaling pathway(GO:0038179) |
0.1 | 0.2 | GO:1900120 | regulation of receptor binding(GO:1900120) |
0.1 | 0.6 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.1 | 0.3 | GO:0007595 | lactation(GO:0007595) |
0.1 | 0.2 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.6 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.1 | 0.2 | GO:0060263 | regulation of respiratory burst(GO:0060263) positive regulation of respiratory burst(GO:0060267) |
0.1 | 0.2 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 1.8 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
0.1 | 0.1 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.1 | 0.1 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.1 | 0.2 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 2.0 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.3 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.1 | 0.2 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 0.1 | GO:0048002 | antigen processing and presentation of peptide antigen(GO:0048002) |
0.1 | 0.7 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.1 | 0.4 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 0.1 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.1 | 0.4 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.3 | GO:0038031 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.8 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.3 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.4 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 1.2 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.1 | 3.6 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.3 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.1 | 0.1 | GO:0044241 | lipid digestion(GO:0044241) |
0.1 | 0.4 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.1 | 0.2 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.3 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.2 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 0.6 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 0.1 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.1 | 0.2 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 3.4 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.1 | 0.1 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.1 | 1.0 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.1 | 0.8 | GO:0006720 | isoprenoid metabolic process(GO:0006720) |
0.1 | 0.2 | GO:0090042 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.1 | 0.1 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.1 | 0.3 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 0.5 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.1 | 0.6 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.2 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.1 | 0.7 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.1 | 1.1 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 0.7 | GO:0071711 | basement membrane organization(GO:0071711) |
0.1 | 0.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.1 | 0.2 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.1 | 0.2 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.1 | 3.4 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 0.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 0.1 | GO:0007494 | midgut development(GO:0007494) |
0.1 | 0.1 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.1 | 0.1 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.1 | 0.7 | GO:0060337 | type I interferon signaling pathway(GO:0060337) |
0.1 | 0.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.1 | 0.1 | GO:0086012 | membrane depolarization during cardiac muscle cell action potential(GO:0086012) |
0.1 | 0.1 | GO:0060022 | hard palate development(GO:0060022) |
0.1 | 0.3 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.1 | 1.0 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 0.2 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.1 | 0.2 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.9 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.1 | 0.4 | GO:0060074 | synapse maturation(GO:0060074) |
0.1 | 1.2 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.1 | 0.1 | GO:0001510 | RNA methylation(GO:0001510) |
0.1 | 0.9 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.8 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.1 | 0.2 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 0.6 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.2 | GO:0030240 | skeletal myofibril assembly(GO:0014866) skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 2.2 | GO:0031638 | zymogen activation(GO:0031638) |
0.1 | 0.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.3 | GO:0006110 | regulation of glycolytic process(GO:0006110) regulation of nucleotide catabolic process(GO:0030811) |
0.1 | 0.5 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.2 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.3 | GO:0006227 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.1 | 0.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.5 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 0.3 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 0.3 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 3.8 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 0.2 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.1 | 0.1 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.1 | 0.3 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.1 | 0.1 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.1 | 0.4 | GO:0050702 | interleukin-1 beta secretion(GO:0050702) |
0.1 | 0.4 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.2 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.1 | 1.2 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.4 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 2.3 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.7 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.1 | 0.1 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.1 | 0.5 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.1 | GO:0072172 | mesonephric tubule formation(GO:0072172) |
0.1 | 0.9 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.1 | 0.5 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.2 | GO:1900117 | regulation of execution phase of apoptosis(GO:1900117) |
0.1 | 0.1 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.1 | 0.7 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.1 | 1.4 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.3 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.2 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.4 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.1 | 0.1 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
0.1 | 0.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.1 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 0.2 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.1 | 0.2 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.1 | 0.3 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 0.2 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.1 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.1 | 1.0 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.1 | 0.1 | GO:0032660 | regulation of interleukin-17 production(GO:0032660) |
0.1 | 0.3 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 1.0 | GO:0045143 | homologous chromosome segregation(GO:0045143) |
0.1 | 4.3 | GO:0007051 | spindle organization(GO:0007051) |
0.1 | 0.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.1 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.1 | 0.2 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.1 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.3 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 0.4 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.1 | 0.6 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 0.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.1 | 0.1 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.1 | 0.5 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.2 | GO:1901142 | insulin metabolic process(GO:1901142) |
0.1 | 1.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.2 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 0.2 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.2 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.2 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.1 | 2.5 | GO:0098656 | anion transmembrane transport(GO:0098656) |
0.1 | 5.9 | GO:0030198 | extracellular matrix organization(GO:0030198) |
0.1 | 0.1 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.1 | 0.5 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.1 | 0.1 | GO:0060460 | left lung morphogenesis(GO:0060460) |
0.1 | 0.6 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 0.7 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.1 | 0.1 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.1 | 0.1 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.1 | 0.4 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.3 | GO:0051132 | NK T cell activation(GO:0051132) |
0.1 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.2 | GO:0045932 | negative regulation of muscle contraction(GO:0045932) |
0.1 | 0.2 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.1 | 0.4 | GO:0007343 | egg activation(GO:0007343) |
0.1 | 0.2 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.1 | 0.1 | GO:0021783 | preganglionic parasympathetic fiber development(GO:0021783) |
0.1 | 0.1 | GO:0015800 | acidic amino acid transport(GO:0015800) |
0.1 | 0.1 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.7 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.1 | 0.1 | GO:0021546 | rhombomere development(GO:0021546) |
0.1 | 0.5 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 0.4 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.1 | 0.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.3 | GO:0051608 | histamine transport(GO:0051608) |
0.1 | 0.1 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 0.2 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.2 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 0.2 | GO:0002369 | T cell cytokine production(GO:0002369) |
0.1 | 0.6 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.1 | 0.7 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.1 | 0.2 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.6 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.1 | GO:0042161 | lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.1 | 0.6 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 1.2 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.6 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 0.6 | GO:0001881 | receptor recycling(GO:0001881) |
0.1 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.3 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 0.1 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.1 | 0.1 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.1 | 0.1 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.1 | 0.3 | GO:0070633 | transepithelial transport(GO:0070633) |
0.1 | 0.3 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.1 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 0.3 | GO:0014002 | astrocyte development(GO:0014002) |
0.1 | 0.1 | GO:0014824 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.1 | 0.1 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) |
0.1 | 0.4 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.1 | GO:0008038 | neuron recognition(GO:0008038) |
0.1 | 0.2 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.1 | 1.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.1 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.1 | 0.3 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 0.1 | GO:0035112 | genitalia morphogenesis(GO:0035112) |
0.1 | 0.2 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.1 | 0.1 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.1 | 0.1 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.7 | GO:0030816 | positive regulation of cAMP metabolic process(GO:0030816) |
0.1 | 0.1 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.1 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 1.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.8 | GO:0006909 | phagocytosis(GO:0006909) |
0.1 | 0.3 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.1 | 0.1 | GO:0045132 | meiotic chromosome segregation(GO:0045132) |
0.1 | 0.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.3 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.4 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 0.1 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 0.4 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 0.3 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.1 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) |
0.1 | 0.2 | GO:0061430 | bone trabecula morphogenesis(GO:0061430) |
0.1 | 0.1 | GO:0045346 | MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) |
0.1 | 0.2 | GO:0036344 | platelet morphogenesis(GO:0036344) |
0.1 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.1 | GO:0002720 | positive regulation of cytokine production involved in immune response(GO:0002720) |
0.1 | 1.5 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 2.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.4 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.1 | 1.2 | GO:0034728 | nucleosome organization(GO:0034728) |
0.1 | 0.2 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.1 | GO:0090313 | regulation of protein targeting to membrane(GO:0090313) |
0.1 | 0.2 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.1 | 0.1 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.1 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.1 | 0.2 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.1 | 0.3 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.3 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) |
0.1 | 0.1 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.1 | 0.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.1 | GO:0090148 | membrane fission(GO:0090148) |
0.1 | 0.3 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 4.1 | GO:0071222 | cellular response to lipopolysaccharide(GO:0071222) |
0.1 | 0.5 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.1 | 0.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.1 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.1 | 0.1 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.1 | 0.2 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.0 | 0.0 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.0 | 2.2 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.0 | 0.1 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
0.0 | 0.1 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.0 | 0.0 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.0 | 0.1 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.0 | 0.2 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.0 | 0.0 | GO:0072677 | eosinophil migration(GO:0072677) |
0.0 | 1.0 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.2 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.0 | 0.2 | GO:0045823 | positive regulation of heart contraction(GO:0045823) |
0.0 | 0.1 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.0 | 1.9 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.0 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.2 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.0 | 0.2 | GO:0060718 | chorion development(GO:0060717) chorionic trophoblast cell differentiation(GO:0060718) extraembryonic membrane development(GO:1903867) |
0.0 | 0.5 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.3 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.0 | 0.4 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.0 | 0.3 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.0 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.0 | 2.3 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.0 | 0.1 | GO:0014841 | skeletal muscle satellite cell proliferation(GO:0014841) regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.0 | 0.3 | GO:0090102 | cochlea development(GO:0090102) |
0.0 | 0.6 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.2 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.0 | 0.1 | GO:0010921 | regulation of phosphatase activity(GO:0010921) |
0.0 | 0.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.2 | GO:0060746 | parental behavior(GO:0060746) |
0.0 | 0.0 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
0.0 | 0.4 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.0 | 0.5 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.0 | 0.1 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.0 | 0.0 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.4 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.0 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.0 | 0.2 | GO:0009409 | response to cold(GO:0009409) |
0.0 | 1.9 | GO:0007188 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway(GO:0007188) |
0.0 | 0.3 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 0.3 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
0.0 | 0.0 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.0 | 0.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.0 | 0.3 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.9 | GO:0098773 | skin epidermis development(GO:0098773) |
0.0 | 0.1 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.0 | 0.1 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.0 | 0.1 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.0 | 0.2 | GO:0002507 | tolerance induction(GO:0002507) |
0.0 | 0.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.0 | 0.3 | GO:1904872 | regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.0 | 1.5 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.1 | GO:0006278 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.0 | 0.0 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.0 | 0.0 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.0 | 0.0 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.0 | 0.1 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.5 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.0 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.0 | 0.3 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.0 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.0 | 0.3 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.0 | 0.3 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.0 | GO:0072202 | distal tubule development(GO:0072017) cell differentiation involved in metanephros development(GO:0072202) metanephric epithelium development(GO:0072207) metanephric nephron epithelium development(GO:0072243) |
0.0 | 0.1 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.0 | 0.4 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
0.0 | 1.4 | GO:0007605 | sensory perception of sound(GO:0007605) |
0.0 | 0.2 | GO:0061371 | determination of heart left/right asymmetry(GO:0061371) |
0.0 | 0.4 | GO:0001570 | vasculogenesis(GO:0001570) |
0.0 | 0.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.0 | 0.7 | GO:0015698 | inorganic anion transport(GO:0015698) |
0.0 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 1.3 | GO:0006813 | potassium ion transport(GO:0006813) |
0.0 | 0.1 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.0 | 0.6 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 0.2 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.1 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.0 | 0.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.0 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.0 | 0.0 | GO:0051095 | regulation of helicase activity(GO:0051095) |
0.0 | 0.2 | GO:0048678 | response to axon injury(GO:0048678) |
0.0 | 0.0 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.0 | 0.1 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.3 | GO:0097576 | vacuole fusion(GO:0097576) |
0.0 | 0.0 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 0.2 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 0.0 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.0 | 0.1 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.0 | 0.0 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.0 | 0.2 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.3 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.0 | 0.1 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.0 | 0.3 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.0 | 0.1 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.0 | 0.0 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.0 | 0.1 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 0.0 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.0 | 0.1 | GO:0030004 | cellular monovalent inorganic cation homeostasis(GO:0030004) |
0.0 | 0.0 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.0 | 0.1 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.0 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
0.0 | 0.0 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.1 | GO:0070986 | left/right axis specification(GO:0070986) |
0.0 | 0.0 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.0 | 0.0 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.0 | 0.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.0 | 0.0 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
0.0 | 0.1 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.0 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.0 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.1 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.0 | GO:0002577 | regulation of antigen processing and presentation(GO:0002577) |
0.0 | 0.0 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.0 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.0 | 0.0 | GO:0051349 | positive regulation of lyase activity(GO:0051349) |
0.0 | 0.0 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.0 | 0.2 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.3 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.3 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.0 | 0.8 | GO:0050953 | sensory perception of light stimulus(GO:0050953) |
0.0 | 0.0 | GO:0060914 | heart formation(GO:0060914) |
0.0 | 0.1 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 0.0 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 | 0.0 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.0 | 0.0 | GO:0033504 | floor plate development(GO:0033504) |
0.0 | 0.0 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.6 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.0 | GO:0038093 | Fc receptor signaling pathway(GO:0038093) |
0.0 | 0.0 | GO:0042439 | ethanolamine-containing compound metabolic process(GO:0042439) |
0.0 | 0.0 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.0 | 0.0 | GO:0032682 | negative regulation of chemokine production(GO:0032682) |
0.0 | 0.1 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.0 | 0.1 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.0 | 0.1 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.0 | 0.0 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.0 | 0.2 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.1 | GO:0006213 | pyrimidine nucleoside metabolic process(GO:0006213) |
0.0 | 0.0 | GO:0018377 | protein myristoylation(GO:0018377) |
0.0 | 0.0 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.0 | 0.0 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.0 | GO:1900135 | positive regulation of renin secretion into blood stream(GO:1900135) |
0.0 | 0.0 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.0 | 0.0 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.0 | 0.4 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.0 | 0.0 | GO:0010574 | regulation of vascular endothelial growth factor production(GO:0010574) |
0.0 | 0.0 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.0 | GO:0014028 | notochord formation(GO:0014028) |
0.0 | 11.0 | GO:0007608 | sensory perception of smell(GO:0007608) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 5.6 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.6 | 9.5 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.4 | 4.3 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.1 | 2.3 | GO:0099738 | cell cortex region(GO:0099738) |
1.1 | 1.1 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
1.1 | 3.2 | GO:0097443 | sorting endosome(GO:0097443) |
1.1 | 4.3 | GO:1990246 | uniplex complex(GO:1990246) |
1.1 | 4.2 | GO:0071141 | SMAD protein complex(GO:0071141) |
1.0 | 6.3 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.0 | 3.1 | GO:0035838 | growing cell tip(GO:0035838) |
1.0 | 7.9 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
1.0 | 6.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.0 | 2.9 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
1.0 | 3.9 | GO:1990696 | USH2 complex(GO:1990696) |
0.9 | 0.9 | GO:0035061 | interchromatin granule(GO:0035061) |
0.9 | 2.7 | GO:0097513 | myosin II filament(GO:0097513) |
0.9 | 9.1 | GO:0031932 | TORC2 complex(GO:0031932) |
0.9 | 2.7 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.8 | 2.5 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.8 | 6.6 | GO:0045179 | apical cortex(GO:0045179) |
0.8 | 1.6 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.8 | 3.3 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.8 | 3.3 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.8 | 6.4 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.8 | 4.0 | GO:0044194 | cytolytic granule(GO:0044194) |
0.8 | 2.4 | GO:0038201 | TOR complex(GO:0038201) |
0.8 | 4.8 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.7 | 2.2 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.7 | 1.4 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.7 | 1.3 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.6 | 1.9 | GO:0005642 | annulate lamellae(GO:0005642) |
0.6 | 1.9 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.6 | 2.4 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.6 | 1.8 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.6 | 1.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.6 | 2.4 | GO:0072487 | MSL complex(GO:0072487) |
0.6 | 1.7 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.6 | 2.3 | GO:0071797 | LUBAC complex(GO:0071797) |
0.6 | 2.8 | GO:0008091 | spectrin(GO:0008091) |
0.6 | 1.7 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.5 | 3.3 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.5 | 2.2 | GO:0071944 | cell periphery(GO:0071944) |
0.5 | 7.7 | GO:0071565 | nBAF complex(GO:0071565) |
0.5 | 3.3 | GO:1990462 | omegasome(GO:1990462) |
0.5 | 1.6 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.5 | 1.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.5 | 0.5 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.5 | 1.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.5 | 1.5 | GO:0071953 | elastic fiber(GO:0071953) |
0.5 | 1.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.5 | 1.5 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.5 | 1.0 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.5 | 5.6 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.5 | 0.5 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.5 | 1.0 | GO:0032437 | cuticular plate(GO:0032437) |
0.5 | 2.0 | GO:0005767 | secondary lysosome(GO:0005767) |
0.5 | 3.0 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.5 | 5.0 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.5 | 1.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.5 | 2.5 | GO:0005638 | lamin filament(GO:0005638) |
0.5 | 1.0 | GO:0005683 | U7 snRNP(GO:0005683) |
0.5 | 3.9 | GO:0000776 | kinetochore(GO:0000776) |
0.5 | 1.5 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.5 | 2.0 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.5 | 0.5 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.5 | 1.9 | GO:0031983 | vesicle lumen(GO:0031983) |
0.5 | 1.9 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.5 | 1.4 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.5 | 3.7 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.5 | 1.9 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.5 | 7.4 | GO:0000145 | exocyst(GO:0000145) |
0.5 | 1.8 | GO:0098552 | side of membrane(GO:0098552) |
0.5 | 0.5 | GO:0070820 | tertiary granule(GO:0070820) |
0.5 | 1.8 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.4 | 0.4 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.4 | 1.3 | GO:0043511 | inhibin complex(GO:0043511) |
0.4 | 0.4 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.4 | 1.8 | GO:0005874 | microtubule(GO:0005874) |
0.4 | 5.7 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.4 | 2.6 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.4 | 2.1 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.4 | 6.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.4 | 0.4 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.4 | 3.4 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.4 | 2.1 | GO:0030914 | STAGA complex(GO:0030914) |
0.4 | 0.4 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.4 | 0.8 | GO:0031523 | Myb complex(GO:0031523) |
0.4 | 2.1 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.4 | 3.7 | GO:0044327 | dendritic spine head(GO:0044327) |
0.4 | 0.4 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.4 | 2.0 | GO:0097255 | R2TP complex(GO:0097255) |
0.4 | 2.0 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.4 | 2.8 | GO:0030008 | TRAPP complex(GO:0030008) |
0.4 | 3.6 | GO:0005869 | dynactin complex(GO:0005869) |
0.4 | 4.0 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.4 | 0.4 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.4 | 5.8 | GO:0001741 | XY body(GO:0001741) |
0.4 | 1.2 | GO:0000243 | commitment complex(GO:0000243) |
0.4 | 1.2 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.4 | 1.5 | GO:0044299 | C-fiber(GO:0044299) |
0.4 | 4.9 | GO:0005614 | interstitial matrix(GO:0005614) |
0.4 | 0.4 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.4 | 1.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.4 | 3.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.4 | 9.8 | GO:0008305 | integrin complex(GO:0008305) |
0.4 | 1.1 | GO:1990923 | PET complex(GO:1990923) |
0.4 | 1.1 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.4 | 2.6 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.4 | 3.3 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.4 | 4.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.4 | 1.5 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.4 | 2.9 | GO:0070652 | HAUS complex(GO:0070652) |
0.4 | 1.8 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.4 | 2.5 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.4 | 0.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.4 | 0.7 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.4 | 7.0 | GO:0030057 | desmosome(GO:0030057) |
0.4 | 1.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.3 | 2.4 | GO:0000801 | central element(GO:0000801) |
0.3 | 3.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.3 | 0.3 | GO:0030118 | clathrin coat(GO:0030118) |
0.3 | 5.1 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.3 | 1.0 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.3 | 2.4 | GO:0005694 | chromosome(GO:0005694) |
0.3 | 1.7 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.3 | 0.3 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.3 | 2.0 | GO:0016589 | NURF complex(GO:0016589) |
0.3 | 1.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.3 | 0.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.3 | 2.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.3 | 1.3 | GO:0070876 | SOSS complex(GO:0070876) |
0.3 | 6.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.3 | 2.9 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 2.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.3 | 1.3 | GO:0000322 | storage vacuole(GO:0000322) |
0.3 | 3.8 | GO:0033270 | paranode region of axon(GO:0033270) |
0.3 | 1.0 | GO:0033503 | HULC complex(GO:0033503) |
0.3 | 5.7 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.3 | 1.9 | GO:0043083 | synaptic cleft(GO:0043083) |
0.3 | 0.3 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.3 | 0.6 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.3 | 2.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.3 | 0.9 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.3 | 0.9 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.3 | 3.1 | GO:0016580 | Sin3 complex(GO:0016580) |
0.3 | 7.9 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.3 | 3.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.3 | 0.9 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.3 | 0.9 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.3 | 0.9 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.3 | 1.5 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.3 | 0.3 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.3 | 2.4 | GO:0036157 | outer dynein arm(GO:0036157) |
0.3 | 3.0 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.3 | 2.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.3 | 1.8 | GO:0000812 | Swr1 complex(GO:0000812) |
0.3 | 0.3 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.3 | 2.3 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.3 | 1.2 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.3 | 0.9 | GO:0043293 | apoptosome(GO:0043293) |
0.3 | 0.3 | GO:0044292 | dendrite terminus(GO:0044292) |
0.3 | 0.9 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.3 | 5.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.3 | 0.3 | GO:0032590 | dendrite membrane(GO:0032590) |
0.3 | 4.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.3 | 2.6 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.3 | 0.8 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.3 | 3.9 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.3 | 1.7 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.3 | 0.6 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.3 | 1.4 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.3 | 3.8 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.3 | 7.6 | GO:0031901 | early endosome membrane(GO:0031901) |
0.3 | 2.4 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.3 | 4.1 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.3 | 5.1 | GO:0043197 | dendritic spine(GO:0043197) |
0.3 | 0.3 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.3 | 0.5 | GO:0043203 | axon hillock(GO:0043203) |
0.3 | 0.8 | GO:0045298 | tubulin complex(GO:0045298) |
0.3 | 12.7 | GO:0032587 | ruffle membrane(GO:0032587) |
0.3 | 4.5 | GO:0012505 | endomembrane system(GO:0012505) |
0.3 | 2.1 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.3 | 9.4 | GO:0031519 | PcG protein complex(GO:0031519) |
0.3 | 1.6 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.3 | 1.3 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.3 | 1.0 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.3 | 1.0 | GO:0071817 | MMXD complex(GO:0071817) |
0.3 | 1.0 | GO:0030897 | HOPS complex(GO:0030897) |
0.3 | 1.8 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.3 | 1.8 | GO:0036477 | somatodendritic compartment(GO:0036477) |
0.3 | 2.8 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 2.0 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 3.7 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 1.7 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.2 | 0.2 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.2 | 0.5 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.2 | 13.9 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.2 | 2.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 0.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 3.7 | GO:0044295 | axonal growth cone(GO:0044295) |
0.2 | 1.0 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 1.2 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.2 | 0.7 | GO:0005745 | m-AAA complex(GO:0005745) |
0.2 | 1.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 0.9 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 2.5 | GO:0036038 | MKS complex(GO:0036038) |
0.2 | 0.9 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.2 | 11.6 | GO:0001726 | ruffle(GO:0001726) |
0.2 | 1.6 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 3.4 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.2 | 1.4 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
0.2 | 0.9 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.2 | 1.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 0.7 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.2 | 1.3 | GO:0030673 | axolemma(GO:0030673) |
0.2 | 2.0 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 0.4 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.2 | 0.7 | GO:0036396 | MIS complex(GO:0036396) |
0.2 | 0.4 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 0.9 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.2 | 12.9 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.2 | 0.6 | GO:0097452 | GAIT complex(GO:0097452) |
0.2 | 0.6 | GO:0042825 | TAP complex(GO:0042825) |
0.2 | 0.8 | GO:1990130 | Iml1 complex(GO:1990130) |
0.2 | 0.6 | GO:0005955 | calcineurin complex(GO:0005955) |
0.2 | 1.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.2 | 2.5 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 1.3 | GO:0097342 | ripoptosome(GO:0097342) |
0.2 | 1.9 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 2.3 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.2 | 1.2 | GO:0031415 | NatA complex(GO:0031415) |
0.2 | 0.6 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.2 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 1.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 0.2 | GO:0019866 | organelle inner membrane(GO:0019866) |
0.2 | 0.8 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.2 | 1.4 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 10.2 | GO:0016363 | nuclear matrix(GO:0016363) |
0.2 | 1.8 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 1.6 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 1.6 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.2 | 3.1 | GO:0002102 | podosome(GO:0002102) |
0.2 | 3.3 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.2 | 0.2 | GO:0098858 | actin-based cell projection(GO:0098858) |
0.2 | 9.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.2 | 1.0 | GO:0097470 | ribbon synapse(GO:0097470) |
0.2 | 1.7 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 0.2 | GO:1990357 | terminal web(GO:1990357) |
0.2 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 5.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.2 | 0.4 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.2 | 1.1 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 1.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 0.6 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 3.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 0.7 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 4.9 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.2 | 0.9 | GO:0031902 | late endosome membrane(GO:0031902) |
0.2 | 1.5 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.2 | 0.6 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.2 | 1.1 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 1.5 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.2 | 0.9 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.2 | 30.3 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.2 | 1.3 | GO:0001650 | fibrillar center(GO:0001650) |
0.2 | 3.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 1.4 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.2 | 0.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 0.9 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 0.5 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.2 | 0.5 | GO:0098797 | plasma membrane protein complex(GO:0098797) |
0.2 | 0.9 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 3.0 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.2 | 1.2 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.2 | 3.5 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.2 | 2.6 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 0.3 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.2 | 0.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 1.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.2 | 1.9 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 1.4 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.2 | 1.5 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.2 | 0.3 | GO:0042581 | specific granule(GO:0042581) |
0.2 | 0.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.2 | 0.3 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 0.2 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.2 | 1.0 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 0.7 | GO:0045177 | apical part of cell(GO:0045177) |
0.2 | 4.4 | GO:0005844 | polysome(GO:0005844) |
0.2 | 0.2 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 0.7 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.2 | 2.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 3.7 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 0.6 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.2 | 0.8 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.2 | 2.4 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.2 | 0.2 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.2 | 0.8 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.2 | 0.3 | GO:0016528 | sarcoplasm(GO:0016528) |
0.2 | 12.1 | GO:0072562 | blood microparticle(GO:0072562) |
0.2 | 1.7 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 0.1 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.1 | 0.4 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 1.9 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.7 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.1 | 1.5 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.3 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 0.9 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 2.5 | GO:0043005 | neuron projection(GO:0043005) |
0.1 | 1.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 10.7 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 2.4 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.6 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 1.0 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.6 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.6 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 1.4 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 3.2 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 1.0 | GO:0031974 | membrane-enclosed lumen(GO:0031974) |
0.1 | 6.6 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.6 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 1.1 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.1 | 0.8 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 1.8 | GO:0034706 | sodium channel complex(GO:0034706) |
0.1 | 2.8 | GO:0005924 | cell-substrate adherens junction(GO:0005924) |
0.1 | 0.4 | GO:0043194 | axon initial segment(GO:0043194) |
0.1 | 0.5 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.5 | GO:0005688 | U6 snRNP(GO:0005688) |
0.1 | 0.4 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 10.1 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 0.4 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 0.1 | GO:0098793 | presynapse(GO:0098793) |
0.1 | 1.3 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 3.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.4 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 1.3 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 3.9 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 0.4 | GO:0097449 | astrocyte projection(GO:0097449) |
0.1 | 0.9 | GO:0070187 | telosome(GO:0070187) |
0.1 | 1.3 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 0.9 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 2.4 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 0.7 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.2 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.1 | 3.8 | GO:0005901 | caveola(GO:0005901) |
0.1 | 1.0 | GO:0061702 | inflammasome complex(GO:0061702) |
0.1 | 1.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 1.3 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 5.2 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 0.2 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 0.8 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 1.0 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.4 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 0.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 4.2 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 0.8 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 1.4 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 1.4 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.4 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.1 | 0.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 1.2 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 1.3 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.4 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.4 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.1 | GO:0044297 | cell body(GO:0044297) |
0.1 | 1.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 2.1 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 4.8 | GO:0031674 | I band(GO:0031674) |
0.1 | 33.0 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.7 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 5.4 | GO:0030427 | site of polarized growth(GO:0030427) |
0.1 | 7.4 | GO:0060076 | excitatory synapse(GO:0060076) |
0.1 | 0.1 | GO:0033646 | host intracellular part(GO:0033646) intracellular region of host(GO:0043656) |
0.1 | 0.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 1.7 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 11.7 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 0.1 | GO:0005819 | spindle(GO:0005819) |
0.1 | 0.8 | GO:0031082 | BLOC complex(GO:0031082) |
0.1 | 0.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.1 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 1.3 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.2 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 4.3 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.9 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 8.1 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 0.6 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.1 | 2.3 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 0.3 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 33.6 | GO:0009986 | cell surface(GO:0009986) |
0.1 | 0.2 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 1.0 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.7 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 1.1 | GO:0044815 | nucleosome(GO:0000786) DNA packaging complex(GO:0044815) |
0.1 | 4.5 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 0.3 | GO:0000803 | sex chromosome(GO:0000803) |
0.1 | 0.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.3 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 1.6 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 0.3 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.1 | 0.7 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.1 | 0.6 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 8.2 | GO:0043025 | neuronal cell body(GO:0043025) |
0.1 | 0.3 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 0.4 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 2.9 | GO:0033267 | axon part(GO:0033267) |
0.1 | 0.5 | GO:0002177 | manchette(GO:0002177) |
0.1 | 72.3 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.1 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.9 | GO:0045202 | synapse(GO:0045202) |
0.1 | 0.3 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 0.3 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 3.0 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 0.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 5.1 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.1 | 0.2 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.1 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.1 | 0.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 0.7 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.1 | 4.6 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 1.1 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.5 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 5.2 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
0.1 | 0.1 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 0.3 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.4 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 4.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 6.9 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 0.1 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 1.8 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 2.2 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.1 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 13.2 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.2 | GO:1904949 | ATPase complex(GO:1904949) |
0.1 | 0.5 | GO:0031011 | Ino80 complex(GO:0031011) |
0.1 | 0.6 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 2.0 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 3.0 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.8 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 0.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 1.3 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 0.1 | GO:0031982 | vesicle(GO:0031982) |
0.1 | 1.0 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.1 | 16.6 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 0.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 1.1 | GO:0030529 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.1 | 0.5 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 2.2 | GO:0072372 | primary cilium(GO:0072372) |
0.1 | 3.5 | GO:0043235 | receptor complex(GO:0043235) |
0.1 | 0.1 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 1.7 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.1 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.1 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 12.6 | GO:0031410 | cytoplasmic vesicle(GO:0031410) |
0.1 | 5.1 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 0.3 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 1.8 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 0.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 2.0 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.2 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 2.1 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.1 | 27.0 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.1 | 2.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.7 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.7 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 57.4 | GO:0043230 | extracellular organelle(GO:0043230) |
0.1 | 0.2 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.1 | 3.5 | GO:0005740 | mitochondrial envelope(GO:0005740) |
0.1 | 0.1 | GO:0005606 | laminin-1 complex(GO:0005606) laminin-3 complex(GO:0005608) |
0.0 | 0.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.0 | GO:0031256 | leading edge membrane(GO:0031256) |
0.0 | 0.0 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.0 | 0.4 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.4 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.0 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 98.2 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 110.6 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 1.2 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
0.0 | 3.2 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.5 | GO:0042995 | cell projection(GO:0042995) |
0.0 | 29.1 | GO:0005737 | cytoplasm(GO:0005737) |
0.0 | 0.1 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 11.2 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.0 | GO:0098536 | deuterosome(GO:0098536) |
0.0 | 0.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 1.5 | GO:0016020 | membrane(GO:0016020) |
0.0 | 4.1 | GO:0005886 | plasma membrane(GO:0005886) |
0.0 | 0.1 | GO:0097223 | sperm part(GO:0097223) |
0.0 | 8.2 | GO:0005576 | extracellular region(GO:0005576) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 10.9 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
2.7 | 8.1 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
2.0 | 10.1 | GO:0004854 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
1.7 | 5.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
1.7 | 13.7 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.5 | 4.4 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
1.4 | 4.2 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
1.4 | 9.6 | GO:0018651 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
1.4 | 2.7 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
1.3 | 3.9 | GO:0001031 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
1.3 | 3.8 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.2 | 3.7 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
1.2 | 6.1 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
1.1 | 3.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.1 | 4.3 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
1.1 | 3.2 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
1.1 | 3.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.0 | 3.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
1.0 | 4.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
1.0 | 3.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.0 | 4.1 | GO:0015232 | heme transporter activity(GO:0015232) |
1.0 | 8.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
1.0 | 11.4 | GO:0017166 | vinculin binding(GO:0017166) |
0.9 | 2.8 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.9 | 2.8 | GO:0005350 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.9 | 6.6 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.9 | 2.8 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.9 | 2.8 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.9 | 4.6 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.9 | 2.8 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.9 | 3.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.9 | 4.5 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.9 | 3.6 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.9 | 2.7 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.9 | 2.6 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.9 | 4.3 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.9 | 2.6 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.8 | 5.1 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.8 | 4.2 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.8 | 0.8 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.8 | 2.5 | GO:0019961 | interferon binding(GO:0019961) |
0.8 | 3.3 | GO:0034889 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.8 | 2.5 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.8 | 9.0 | GO:0051400 | BH domain binding(GO:0051400) |
0.8 | 2.4 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.8 | 2.4 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.8 | 3.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.8 | 3.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.8 | 2.3 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.7 | 2.2 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.7 | 0.7 | GO:0019213 | deacetylase activity(GO:0019213) |
0.7 | 3.7 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.7 | 2.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.7 | 2.9 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.7 | 5.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.7 | 4.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.7 | 5.0 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.7 | 2.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.7 | 2.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.7 | 4.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.7 | 4.0 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.7 | 9.9 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.7 | 3.3 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.6 | 8.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.6 | 2.6 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.6 | 3.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.6 | 6.4 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.6 | 3.8 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.6 | 9.6 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.6 | 1.3 | GO:0030984 | kininogen binding(GO:0030984) |
0.6 | 11.3 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.6 | 0.6 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.6 | 1.2 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.6 | 5.6 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.6 | 2.5 | GO:0045340 | mercury ion binding(GO:0045340) |
0.6 | 1.9 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.6 | 3.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.6 | 2.5 | GO:0031433 | telethonin binding(GO:0031433) |
0.6 | 0.6 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.6 | 3.0 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.6 | 1.8 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.6 | 13.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.6 | 1.2 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.6 | 4.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.6 | 2.9 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.6 | 1.8 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.6 | 2.9 | GO:0070061 | fructose binding(GO:0070061) |
0.6 | 2.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.6 | 2.3 | GO:0042731 | PH domain binding(GO:0042731) |
0.6 | 1.7 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.6 | 2.3 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.6 | 2.3 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.6 | 0.6 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.6 | 2.9 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.6 | 1.1 | GO:0070538 | oleic acid binding(GO:0070538) |
0.6 | 2.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.6 | 1.7 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.5 | 1.1 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.5 | 1.6 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.5 | 2.2 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.5 | 4.3 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.5 | 3.8 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.5 | 3.2 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.5 | 2.7 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.5 | 6.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.5 | 3.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.5 | 1.6 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.5 | 1.6 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.5 | 6.8 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.5 | 3.1 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.5 | 0.5 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.5 | 1.6 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.5 | 16.5 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.5 | 2.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.5 | 1.5 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.5 | 1.5 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.5 | 1.0 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.5 | 1.5 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.5 | 1.5 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.5 | 0.5 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.5 | 0.5 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.5 | 1.5 | GO:0035939 | microsatellite binding(GO:0035939) |
0.5 | 6.6 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.5 | 0.5 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.5 | 2.0 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.5 | 2.0 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.5 | 0.5 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.5 | 3.5 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.5 | 2.5 | GO:0030957 | Tat protein binding(GO:0030957) |
0.5 | 2.0 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.5 | 3.0 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.5 | 0.5 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.5 | 1.5 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.5 | 4.9 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.5 | 0.5 | GO:0032142 | DNA insertion or deletion binding(GO:0032135) single base insertion or deletion binding(GO:0032138) dinucleotide insertion or deletion binding(GO:0032139) single guanine insertion binding(GO:0032142) |
0.5 | 3.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.5 | 2.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.5 | 3.9 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.5 | 3.8 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.5 | 1.4 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.5 | 1.4 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.5 | 5.7 | GO:0005521 | lamin binding(GO:0005521) |
0.5 | 2.8 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.5 | 1.9 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.5 | 3.8 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.5 | 1.9 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.5 | 3.3 | GO:0016208 | AMP binding(GO:0016208) |
0.5 | 1.9 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.5 | 2.3 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.5 | 0.5 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.5 | 6.0 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.5 | 1.4 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.5 | 3.7 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.5 | 4.6 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.5 | 2.7 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.5 | 3.2 | GO:0033691 | sialic acid binding(GO:0033691) |
0.4 | 3.6 | GO:0034821 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.4 | 4.4 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.4 | 1.8 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.4 | 5.3 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.4 | 4.4 | GO:0015266 | protein channel activity(GO:0015266) |
0.4 | 1.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.4 | 0.4 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.4 | 2.2 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.4 | 1.3 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.4 | 3.0 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.4 | 1.3 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.4 | 23.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.4 | 2.1 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.4 | 1.3 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.4 | 6.7 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.4 | 2.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.4 | 2.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.4 | 2.5 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.4 | 2.8 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.4 | 1.6 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.4 | 1.6 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.4 | 1.2 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.4 | 0.4 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.4 | 4.0 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.4 | 1.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.4 | 4.0 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.4 | 1.6 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.4 | 0.4 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.4 | 0.4 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.4 | 0.8 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.4 | 0.8 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.4 | 0.4 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.4 | 4.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.4 | 0.8 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.4 | 1.1 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.4 | 5.3 | GO:0030955 | potassium ion binding(GO:0030955) |
0.4 | 0.8 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.4 | 6.8 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.4 | 1.9 | GO:0035473 | lipase binding(GO:0035473) |
0.4 | 2.6 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.4 | 1.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.4 | 1.5 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.4 | 1.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.4 | 2.9 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.4 | 2.6 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.4 | 4.0 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.4 | 5.8 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.4 | 1.5 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.4 | 1.4 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.4 | 1.8 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.4 | 7.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.4 | 2.1 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.4 | 5.0 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.4 | 2.8 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.4 | 1.1 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.3 | 2.1 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.3 | 1.0 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.3 | 1.4 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.3 | 1.0 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.3 | 5.5 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.3 | 1.7 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 0.7 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.3 | 1.7 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.3 | 1.0 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.3 | 1.0 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.3 | 1.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.3 | 4.1 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.3 | 65.9 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.3 | 0.3 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.3 | 3.0 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.3 | 1.0 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.3 | 1.0 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.3 | 1.0 | GO:2001070 | starch binding(GO:2001070) |
0.3 | 3.9 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.3 | 1.6 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.3 | 3.6 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.3 | 1.0 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.3 | 2.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 4.8 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.3 | 1.0 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.3 | 0.6 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.3 | 0.6 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.3 | 0.3 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.3 | 0.3 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.3 | 5.9 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.3 | 1.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.3 | 1.2 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.3 | 0.9 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.3 | 1.8 | GO:0008494 | translation activator activity(GO:0008494) |
0.3 | 2.5 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.3 | 0.6 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.3 | 3.4 | GO:0030371 | translation repressor activity(GO:0030371) |
0.3 | 2.2 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.3 | 0.9 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.3 | 0.9 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.3 | 0.9 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.3 | 1.2 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.3 | 3.3 | GO:0001618 | virus receptor activity(GO:0001618) |
0.3 | 0.6 | GO:1990405 | protein antigen binding(GO:1990405) |
0.3 | 1.5 | GO:0016936 | galactoside binding(GO:0016936) |
0.3 | 0.9 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.3 | 0.6 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.3 | 2.4 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.3 | 1.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.3 | 0.6 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.3 | 0.9 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.3 | 0.6 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.3 | 0.6 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) purine-specific mismatch base pair DNA N-glycosylase activity(GO:0000701) single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.3 | 1.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.3 | 12.3 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.3 | 7.1 | GO:0045296 | cadherin binding(GO:0045296) |
0.3 | 2.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 0.8 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.3 | 2.8 | GO:0019841 | retinol binding(GO:0019841) |
0.3 | 1.7 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.3 | 2.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.3 | 1.4 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.3 | 1.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.3 | 0.3 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.3 | 0.6 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.3 | 0.6 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.3 | 0.8 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.3 | 0.8 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.3 | 2.5 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.3 | 5.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.3 | 2.2 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.3 | 0.8 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.3 | 1.6 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.3 | 3.0 | GO:0031404 | chloride ion binding(GO:0031404) |
0.3 | 2.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.3 | 1.9 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.3 | 0.8 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.3 | 4.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.3 | 2.7 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.3 | 5.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 1.3 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.3 | 2.9 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.3 | 0.8 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.3 | 1.6 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.3 | 1.9 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.3 | 1.3 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.3 | 0.8 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.3 | 0.8 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.3 | 2.9 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.3 | 0.8 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.3 | 0.8 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.3 | 1.8 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.3 | 0.8 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.3 | 1.3 | GO:0000150 | recombinase activity(GO:0000150) |
0.3 | 0.8 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.3 | 1.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.3 | 1.3 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.3 | 1.6 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.3 | 0.5 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.3 | 0.3 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.3 | 1.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.3 | 0.5 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.3 | 4.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.3 | 1.5 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.3 | 2.0 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.3 | 1.5 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.3 | 0.3 | GO:0046790 | virion binding(GO:0046790) |
0.3 | 1.8 | GO:0034951 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.3 | 0.8 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.3 | 1.0 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.3 | 0.5 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.3 | 0.8 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.3 | 0.8 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.3 | 3.0 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.3 | 0.8 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.3 | 2.5 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.3 | 1.0 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.2 | 1.2 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.2 | 0.5 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.2 | 0.2 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.2 | 1.7 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.2 | 8.2 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 1.0 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.2 | 2.0 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.2 | 1.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 0.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 0.7 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.2 | 0.7 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.2 | 2.9 | GO:0005542 | folic acid binding(GO:0005542) |
0.2 | 1.9 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.2 | 1.7 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.2 | 1.9 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 0.5 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.2 | 0.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.2 | 2.4 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 0.2 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.2 | 0.2 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.2 | 1.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 1.4 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.2 | 1.4 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 4.2 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.2 | 10.0 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.2 | 4.4 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.2 | 1.6 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.2 | 0.5 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.2 | 2.1 | GO:0048156 | tau protein binding(GO:0048156) |
0.2 | 2.7 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.2 | 3.6 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.2 | 0.7 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 0.2 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 2.5 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.2 | 2.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.2 | 4.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.2 | 3.1 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.2 | 0.7 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.2 | 1.1 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.2 | 1.3 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.2 | 0.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.2 | 2.8 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.2 | 1.1 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 3.5 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.2 | 2.2 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.2 | 0.6 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.2 | 1.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 1.5 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.2 | 0.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 0.4 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.2 | 0.8 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.2 | 1.9 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.2 | 0.6 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 0.8 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 0.8 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.2 | 0.2 | GO:0046030 | inositol trisphosphate phosphatase activity(GO:0046030) |
0.2 | 0.6 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.2 | 1.4 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.2 | 2.0 | GO:0008143 | poly(A) binding(GO:0008143) |
0.2 | 0.6 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 3.2 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 0.6 | GO:0070905 | serine binding(GO:0070905) |
0.2 | 1.8 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.2 | 10.7 | GO:0017022 | myosin binding(GO:0017022) |
0.2 | 1.0 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.2 | 0.8 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.2 | 3.2 | GO:0019198 | transmembrane receptor protein phosphatase activity(GO:0019198) |
0.2 | 1.8 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 0.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 0.8 | GO:0005534 | galactose binding(GO:0005534) |
0.2 | 0.4 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.2 | 1.0 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.2 | 5.5 | GO:0016209 | antioxidant activity(GO:0016209) |
0.2 | 2.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 4.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 0.2 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.2 | 2.9 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.2 | 1.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.2 | 1.0 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 7.4 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.2 | 0.4 | GO:0000182 | rDNA binding(GO:0000182) |
0.2 | 3.8 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.2 | 0.4 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.2 | 0.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 0.2 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.2 | 0.4 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.2 | 2.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 1.7 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.2 | 0.6 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.2 | 0.9 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.2 | 1.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 0.7 | GO:0036033 | mediator complex binding(GO:0036033) |
0.2 | 1.3 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.2 | 0.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.2 | 3.1 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.2 | 1.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 7.9 | GO:0008907 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.2 | 0.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.2 | 0.7 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.2 | 1.6 | GO:0008932 | lytic endotransglycosylase activity(GO:0008932) |
0.2 | 1.1 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.2 | 0.7 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.2 | 0.7 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.2 | 1.4 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 0.4 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.2 | 3.2 | GO:0045502 | dynein binding(GO:0045502) |
0.2 | 0.4 | GO:0060229 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.2 | 0.7 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.2 | 0.7 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.2 | 0.9 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 10.0 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.2 | 0.5 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 1.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 0.3 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.2 | 4.1 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 3.6 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.2 | 0.7 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.2 | 3.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 1.4 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.2 | 1.0 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 0.3 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.2 | 0.2 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.2 | 8.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 0.5 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.2 | 0.3 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.2 | 0.7 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 0.5 | GO:0001968 | fibronectin binding(GO:0001968) |
0.2 | 1.2 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.2 | 1.7 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.2 | 0.7 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.2 | 5.8 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.2 | 0.5 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.2 | 1.5 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.2 | 0.5 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.2 | 0.5 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 0.3 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.2 | 2.4 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.2 | 2.6 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 0.6 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.2 | 0.8 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 1.0 | GO:0036122 | BMP binding(GO:0036122) |
0.2 | 0.8 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 2.4 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.2 | 0.5 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.2 | 0.3 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 1.1 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.2 | 0.5 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.2 | 0.5 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.2 | 0.3 | GO:0032052 | bile acid binding(GO:0032052) |
0.2 | 2.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 0.5 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.2 | 0.3 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.2 | 0.5 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.4 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.1 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 0.7 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 0.3 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.1 | 1.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.4 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 0.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 1.0 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.4 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.1 | 1.7 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 1.4 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 0.7 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 2.1 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 1.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.1 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.1 | 10.3 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 2.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 1.8 | GO:0033558 | protein deacetylase activity(GO:0033558) |
0.1 | 4.1 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.9 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 0.5 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 4.8 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 1.9 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.1 | 0.9 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 2.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.7 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.4 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.1 | 1.3 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.5 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 0.4 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 0.9 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.1 | 1.4 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 7.9 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 20.8 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.1 | 0.3 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.1 | 0.5 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.5 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 0.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 1.2 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.5 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.4 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.1 | 0.5 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 0.5 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 1.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 9.6 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 3.8 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.4 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 1.6 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.4 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 4.6 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 1.0 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 2.1 | GO:0005186 | pheromone activity(GO:0005186) |
0.1 | 5.0 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 1.0 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 1.7 | GO:0000907 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.1 | 0.9 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.4 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.1 | GO:0048403 | neurotrophin binding(GO:0043121) brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 1.3 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.4 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 4.5 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 0.6 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 1.3 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 1.4 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.6 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.5 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.1 | 0.6 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.1 | GO:0030172 | troponin C binding(GO:0030172) |
0.1 | 6.4 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 0.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.3 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.8 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 3.3 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 1.9 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 0.5 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 0.7 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 6.4 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.6 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 18.5 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.1 | 0.4 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 2.9 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.1 | 0.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 0.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.2 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 1.0 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.2 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 2.8 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.6 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.1 | 0.1 | GO:0097617 | annealing helicase activity(GO:0036310) annealing activity(GO:0097617) |
0.1 | 0.3 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.1 | 2.6 | GO:0019887 | protein kinase regulator activity(GO:0019887) |
0.1 | 0.1 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.1 | 1.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 2.4 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 0.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 0.7 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 3.0 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.1 | 0.9 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.1 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.1 | 0.1 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.1 | 0.8 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.9 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 4.7 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.3 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.1 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.1 | 1.5 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 0.8 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.1 | 0.5 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.5 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 2.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.3 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 1.7 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 0.2 | GO:0033265 | choline binding(GO:0033265) |
0.1 | 2.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 16.3 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.1 | 0.3 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.1 | 2.3 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 1.3 | GO:0022840 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.1 | 1.9 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.9 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.9 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.4 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 5.1 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.1 | 0.3 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.2 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 0.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.8 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 4.2 | GO:0004519 | endonuclease activity(GO:0004519) |
0.1 | 0.4 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 0.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 0.1 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.1 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.6 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 2.2 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.1 | 0.2 | GO:0015321 | sodium:phosphate symporter activity(GO:0005436) sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 3.5 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 4.1 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 2.0 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.4 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.1 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 0.2 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.1 | 0.5 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.5 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 1.1 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.1 | GO:0070697 | activin receptor binding(GO:0070697) |
0.1 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 0.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 2.2 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.1 | 0.9 | GO:0015662 | ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism(GO:0015662) |
0.1 | 3.4 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.1 | 0.1 | GO:0052872 | tocotrienol omega-hydroxylase activity(GO:0052872) |
0.1 | 15.6 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.1 | 1.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 6.2 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 0.3 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 3.5 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 3.7 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 1.2 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.3 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 0.5 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 0.4 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.9 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.1 | 0.3 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 0.7 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 1.0 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 0.1 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 0.2 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.1 | GO:0015265 | urea channel activity(GO:0015265) |
0.1 | 1.1 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.2 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.1 | 0.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 0.2 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.1 | 0.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 1.9 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 0.2 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.1 | 1.7 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.6 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 1.9 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 0.3 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.1 | 0.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.7 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 1.4 | GO:0019838 | growth factor binding(GO:0019838) |
0.1 | 4.4 | GO:0072509 | divalent inorganic cation transmembrane transporter activity(GO:0072509) |
0.1 | 0.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.5 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 1.9 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.1 | 0.1 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.2 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 0.1 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.1 | 0.3 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 0.3 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 4.6 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.1 | 0.2 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 1.2 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 0.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 1.4 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.1 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.0 | 1.7 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 1.1 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.3 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.8 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 3.0 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.1 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.0 | 0.0 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.0 | 2.8 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 2.5 | GO:0003729 | mRNA binding(GO:0003729) |
0.0 | 0.3 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 0.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 0.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.1 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.2 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.2 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.8 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.0 | 0.0 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.0 | 0.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.0 | 0.0 | GO:0023023 | MHC protein complex binding(GO:0023023) |
0.0 | 0.0 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.0 | 0.1 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.0 | 0.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.2 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.0 | 0.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.0 | 0.2 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.0 | 0.9 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.0 | GO:0034859 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.0 | 1.7 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.0 | 0.1 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.0 | 0.1 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.0 | 0.1 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.0 | 0.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.6 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 0.0 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.0 | 0.1 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 6.5 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.1 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.0 | 0.0 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.1 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.0 | 0.0 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.0 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 3.4 | GO:0005198 | structural molecule activity(GO:0005198) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 3.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.7 | 1.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.7 | 29.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.6 | 1.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.6 | 15.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.6 | 35.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.6 | 8.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.6 | 1.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.5 | 4.6 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.5 | 1.0 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.5 | 9.2 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.5 | 4.0 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.5 | 17.0 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.5 | 1.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.5 | 6.6 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.5 | 11.1 | PID RAS PATHWAY | Regulation of Ras family activation |
0.5 | 5.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.4 | 11.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.4 | 8.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.4 | 4.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.4 | 0.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.4 | 2.5 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.4 | 2.5 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.4 | 11.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.4 | 0.4 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.4 | 10.0 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.4 | 9.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.4 | 0.4 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.4 | 3.6 | PID ALK2 PATHWAY | ALK2 signaling events |
0.4 | 1.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.3 | 21.6 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.3 | 0.7 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.3 | 0.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.3 | 4.9 | PID INSULIN PATHWAY | Insulin Pathway |
0.3 | 5.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 2.7 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.3 | 6.6 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.3 | 3.1 | PID ALK1 PATHWAY | ALK1 signaling events |
0.3 | 2.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.3 | 0.8 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.3 | 2.9 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 9.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.3 | 2.6 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 1.0 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.2 | 9.8 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 2.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 2.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 6.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 6.7 | PID BMP PATHWAY | BMP receptor signaling |
0.2 | 2.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 1.6 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 2.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 2.0 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 5.2 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.2 | 0.7 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.2 | 2.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 5.2 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.2 | 3.7 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 6.2 | PID ATR PATHWAY | ATR signaling pathway |
0.2 | 2.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 0.6 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 3.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 8.5 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 0.4 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 1.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 2.9 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.2 | 3.8 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 5.6 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 0.2 | ST GAQ PATHWAY | G alpha q Pathway |
0.2 | 2.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 5.5 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.2 | 4.1 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.2 | 8.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 7.4 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.2 | 22.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 3.3 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 1.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 0.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 0.6 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.2 | 0.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 0.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 1.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 2.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 2.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 28.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 10.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 2.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 0.8 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 0.9 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.4 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 2.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 1.8 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 1.8 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 1.9 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 1.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 1.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 1.5 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 0.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 3.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 0.4 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 1.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 1.2 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 0.5 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 1.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 1.7 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 0.9 | PID ATM PATHWAY | ATM pathway |
0.1 | 1.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.9 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 3.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 1.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 1.0 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 0.5 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 0.5 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 1.1 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 0.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 1.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.6 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 0.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 1.9 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 0.8 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 0.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 0.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 0.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.0 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 2.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.0 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.2 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.2 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
1.1 | 1.1 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
1.0 | 1.0 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.9 | 4.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.9 | 13.4 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.7 | 1.5 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.7 | 2.2 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.7 | 6.9 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.6 | 9.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.6 | 10.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.6 | 3.7 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.6 | 4.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.6 | 0.6 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.6 | 0.6 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.5 | 5.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.5 | 1.1 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.5 | 0.5 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.5 | 5.3 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.5 | 14.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.5 | 5.8 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.5 | 4.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.5 | 6.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.5 | 2.5 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.5 | 8.8 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.5 | 3.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.5 | 0.9 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.5 | 4.7 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.5 | 4.7 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.5 | 10.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.4 | 7.5 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.4 | 4.8 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.4 | 0.4 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.4 | 1.7 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.4 | 7.0 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.4 | 4.0 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.4 | 1.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.4 | 2.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.4 | 3.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.4 | 11.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.4 | 6.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.4 | 4.6 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.4 | 5.7 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.4 | 1.9 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.4 | 3.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.4 | 3.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.4 | 2.2 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.4 | 18.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.4 | 3.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.4 | 8.6 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.4 | 38.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.4 | 1.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.3 | 6.3 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.3 | 4.2 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.3 | 6.5 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.3 | 0.7 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.3 | 1.4 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.3 | 0.3 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.3 | 1.3 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.3 | 9.4 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.3 | 7.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.3 | 3.7 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.3 | 7.0 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.3 | 3.0 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.3 | 2.0 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.3 | 3.6 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.3 | 3.8 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.3 | 1.8 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.3 | 0.9 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.3 | 6.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.3 | 3.0 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.3 | 6.3 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.3 | 2.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.3 | 0.6 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.3 | 1.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.3 | 2.8 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.3 | 1.7 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.3 | 1.1 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.3 | 2.7 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.3 | 5.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.3 | 5.1 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.3 | 4.2 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.3 | 12.6 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.3 | 6.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.3 | 3.1 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.3 | 1.8 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.3 | 2.3 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.3 | 1.8 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.3 | 13.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.3 | 0.8 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.2 | 1.0 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 1.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.2 | 1.5 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.2 | 3.4 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.2 | 5.8 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.2 | 0.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 0.2 | REACTOME OPSINS | Genes involved in Opsins |
0.2 | 0.7 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.2 | 7.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 2.7 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.2 | 1.5 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 4.6 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.2 | 2.2 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.2 | 2.6 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.2 | 1.1 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 7.8 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.2 | 1.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.2 | 6.1 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 0.6 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.2 | 4.6 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.2 | 12.3 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.2 | 1.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.2 | 1.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.2 | 0.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 3.6 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.2 | 3.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.2 | 3.5 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 1.0 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 2.9 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.2 | 1.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 0.6 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.2 | 0.6 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 0.5 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.2 | 0.2 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.2 | 5.0 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.2 | 3.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 1.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.2 | 1.0 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 1.9 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 1.5 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.2 | 0.3 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.2 | 12.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 2.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.2 | 0.2 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.2 | 1.0 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.2 | 0.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 7.2 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.2 | 3.0 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 1.8 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 1.9 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 1.9 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 0.6 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 0.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 4.2 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 1.4 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.1 | 0.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 1.9 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 1.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 0.4 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 1.0 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 3.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 1.6 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.1 | 3.0 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 0.4 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 2.1 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 0.5 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 0.4 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 0.9 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 11.4 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 0.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 1.1 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.5 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 1.1 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 1.7 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 4.9 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.6 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 0.2 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 4.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 1.7 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 3.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 1.5 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 0.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.2 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 0.7 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.1 | 0.9 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 1.6 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 1.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 4.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 2.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 1.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.7 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 1.0 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 0.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 6.9 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 0.3 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 0.9 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.1 | 5.6 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 1.2 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 0.8 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 0.5 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 0.4 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 2.0 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 1.3 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.1 | 0.8 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 0.4 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 2.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 6.3 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 0.3 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 0.6 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.1 | 0.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 0.7 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 0.5 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 0.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 0.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 0.4 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 0.1 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 0.3 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 1.7 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.1 | 0.1 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.1 | 0.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 0.3 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 0.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.5 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.9 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.8 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.0 | 0.6 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.1 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.0 | 5.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.9 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.0 | 0.6 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.2 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.1 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.0 | 0.8 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 3.3 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.1 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.0 | 0.5 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 1.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.5 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 0.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.6 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.1 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.3 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.6 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |